Pathological processes involving the URETERS.
Abnormal enlargement or swelling of a KIDNEY due to dilation of the KIDNEY CALICES and the KIDNEY PELVIS. It is often associated with obstruction of the URETER or chronic kidney diseases that prevents normal drainage of urine into the URINARY BLADDER.
Endoscopic examination, therapy or surgery of the ureter.
Blockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy.
Radiography of any part of the urinary tract.
Stones in the URETER that are formed in the KIDNEY. They are rarely more than 5 mm in diameter for larger renal stones cannot enter ureters. They are often lodged at the ureteral narrowing and can cause excruciating renal colic.
The duct which coveys URINE from the pelvis of the KIDNEY through the URETERS, BLADDER, and URETHRA.
A rare congenital abnormality resulting in the URETER passing dorsal to and being obstructed by the INFERIOR VENA CAVA.
Retrograde flow of urine from the URINARY BLADDER into the URETER. This is often due to incompetence of the vesicoureteral valve leading to ascending bacterial infection into the KIDNEY.
Surgery performed on the urinary tract or its parts in the male or female. For surgery of the male genitalia, UROLOGIC SURGICAL PROCEDURES, MALE is available.
The destruction of a calculus of the kidney, ureter, bladder, or gallbladder by physical forces, including crushing with a lithotriptor through a catheter. Focused percutaneous ultrasound and focused hydraulic shock waves may be used without surgery. Lithotripsy does not include the dissolving of stones by acids or litholysis. Lithotripsy by laser is LITHOTRIPSY, LASER.
The epithelial lining of the URINARY TRACT.
All the organs involved in reproduction and the formation and release of URINE. It includes the kidneys, ureters, BLADDER; URETHRA, and the organs of reproduction - ovaries, UTERUS; FALLOPIAN TUBES; VAGINA; and CLITORIS in women and the testes; SEMINAL VESICLES; PROSTATE; seminal ducts; and PENIS in men.
A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION.
Endoscopes for examining the interior of the ureter.
Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.
Surgical formation of an opening in the ureter for external drainage of the urine; cutaneous route utilizes a ureteral orifice emerging through the skin.
An abnormal passage in any part of the URINARY TRACT between itself or with other organs.
Temporary or permanent diversion of the flow of urine through the ureter away from the URINARY BLADDER in the presence of a bladder disease or after cystectomy. There is a variety of techniques: direct anastomosis of ureter and bowel, cutaneous ureterostomy, ileal, jejunal or colon conduit, ureterosigmoidostomy, etc. (From Campbell's Urology, 6th ed, p2654)
A cystic dilatation of the end of a URETER as it enters into the URINARY BLADDER. It is characterized by the ballooning of the ureteral orifice into the lumen of the bladder and may obstruct urine flow.
Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed)
Excision of kidney.
A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
Endoscopic examination, therapy or surgery of the urinary bladder.
Low-density crystals or stones in any part of the URINARY TRACT. Their chemical compositions often include CALCIUM OXALATE, magnesium ammonium phosphate (struvite), CYSTINE, or URIC ACID.
Tumors or cancer of the URINARY TRACT in either the male or the female.
An area occupying the most posterior aspect of the ABDOMINAL CAVITY. It is bounded laterally by the borders of the quadratus lumborum muscles and extends from the DIAPHRAGM to the brim of the true PELVIS, where it continues as the pelvic extraperitoneal space.
Painful URINATION. It is often associated with infections of the lower URINARY TRACT.
Stones in the KIDNEY, usually formed in the urine-collecting area of the kidney (KIDNEY PELVIS). Their sizes vary and most contains CALCIUM OXALATE.
A slowly progressive condition of unknown etiology, characterized by deposition of fibrous tissue in the retroperitoneal space compressing the ureters, great vessels, bile duct, and other structures. When associated with abdominal aortic aneurysm, it may be called chronic periaortitis or inflammatory perianeurysmal fibrosis.
A procedure in which a laparoscope (LAPAROSCOPES) is inserted through a small incision near the navel to examine the abdominal and pelvic organs in the PERITONEAL CAVITY. If appropriate, biopsy or surgery can be performed during laparoscopy.
A uroplakin subtype that heterodimerizes with UROPLAKIN IB to form a component of the asymmetric unit membrane found in urothelial cells.
A nongenetic defect due to malformation of the KIDNEY which appears as a bunch of grapes with multiple renal cysts but lacking the normal renal bean shape, and the collection drainage system. This condition can be detected in-utero with ULTRASONOGRAPHY.
An abnormal anatomical passage that connects the VAGINA to other organs, such as the bladder (VESICOVAGINAL FISTULA) or the rectum (RECTOVAGINAL FISTULA).
Congenital structural abnormalities of the UROGENITAL SYSTEM in either the male or the female.
Recesses of the kidney pelvis which divides into two wide, cup-shaped major renal calices, with each major calix subdivided into 7 to 14 minor calices. Urine empties into a minor calix from collecting tubules, then passes through the major calix, renal pelvis, and ureter to enter the urinary bladder. (From Moore, Clinically Oriented Anatomy, 3d ed, p211)
A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research.
Passage of a CATHETER into the URINARY BLADDER or kidney.
Digital image data sets, consisting of complete, anatomically detailed, three-dimensional representations of the normal male and female human bodies.
Pathological processes of the URINARY TRACT in both males and females.
Properties, functions, and processes of the URINARY TRACT as a whole or of any of its parts.
A rare aggressive variant of chondrosarcoma, characterized by a biphasic histologic pattern of small compact cells intermixed with islands of cartilaginous matrix. Mesenchymal chondrosarcomas have a predilection for flat bones; long tubular bones are rarely affected. They tend to occur in the younger age group and are highly metastatic. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1456)
Tumors or cancer of the pelvic region.
The insertion of a catheter through the skin and body wall into the kidney pelvis, mainly to provide urine drainage where the ureter is not functional. It is used also to remove or dissolve renal calculi and to diagnose ureteral obstruction.
Inflammation of the KIDNEY involving the renal parenchyma (the NEPHRONS); KIDNEY PELVIS; and KIDNEY CALICES. It is characterized by ABDOMINAL PAIN; FEVER; NAUSEA; VOMITING; and occasionally DIARRHEA.
A Wnt protein that is involved in regulating multiple developmental processes such as the formation of the KIDNEY; ADRENAL GLANDS; MAMMARY GLANDS; the PITUITARY GLAND; and the female reproductive system. Defects in WNT4 are a cause of ROKITANSKY KUSTER HAUSER SYNDROME.
A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.
Pathological processes of the URINARY BLADDER.
Tumors or cancers of the KIDNEY.
Antimuscarinic quaternary ammonium derivative of scopolamine used to treat cramps in gastrointestinal, urinary, uterine, and biliary tracts, and to facilitate radiologic visualization of the gastrointestinal tract.
Tumors or cancer of the URINARY BLADDER.
Presence of blood in the urine.
A type I keratin found in the basal layer of the adult epidermis and in other stratified epithelia.
A paired box transcription factor that is essential for ORGANOGENESIS of the CENTRAL NERVOUS SYSTEM and KIDNEY.
A movement, caused by sequential muscle contraction, that pushes the contents of the intestines or other tubular organs in one direction.
The duration of a surgical procedure in hours and minutes.
Excision of the uterus.
Organs or parts of organs surgically formed from nearby tissue to function as substitutes for diseased or surgically removed tissue.
Long convoluted tubules in the nephrons. They collect filtrate from blood passing through the KIDNEY GLOMERULUS and process this filtrate into URINE. Each renal tubule consists of a BOWMAN CAPSULE; PROXIMAL KIDNEY TUBULE; LOOP OF HENLE; DISTAL KIDNEY TUBULE; and KIDNEY COLLECTING DUCT leading to the central cavity of the kidney (KIDNEY PELVIS) that connects to the URETER.
Surgical creation of an opening (stoma) in the URINARY BLADDER for drainage.
A mass of histologically normal tissue present in an abnormal location.
An antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide.
Tumors or cancer of the UROGENITAL SYSTEM in either the male or the female.
The condition of an anatomical structure's being dilated beyond normal dimensions.
Any adverse condition in a patient occurring as the result of treatment by a physician, surgeon, or other health professional, especially infections acquired by a patient during the course of treatment.
Surgery performed on the male genitalia.
The founding member of the glial cell line-derived neurotrophic factor family. It was originally characterized as a NERVE GROWTH FACTOR promoting the survival of MIDBRAIN dopaminergic NEURONS, and it has been studied as a potential treatment for PARKINSON DISEASE.
Pathological processes involving the URETHRA.
Devices to be inserted into veins or arteries for the purpose of carrying fluids into or from a peripheral or central vascular location. They may include component parts such as catheters, ports, reservoirs, and valves. They may be left in place temporarily for therapeutic or diagnostic purposes.
Cancer or tumors of the URETHRA. Benign epithelial tumors of the urethra usually consist of squamous and transitional cells. Primary urethral carcinomas are rare and typically of squamous cells. Urethral carcinoma is the only urological malignancy that is more common in females than in males.
Used for excision of the urinary bladder.
Short thick veins which return blood from the kidneys to the vena cava.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Stones in the URINARY BLADDER; also known as vesical calculi, bladder stones, or cystoliths.
A derivative of the NIACINAMIDE that is structurally combined with an organic nitrate. It is a potassium-channel opener that causes vasodilatation of arterioles and large coronary arteries. Its nitrate-like properties produce venous vasodilation through stimulation of guanylate cyclase.
An abnormal concretion occurring mostly in the urinary and biliary tracts, usually composed of mineral salts. Also called stones.
Compounds with a core of fused benzo-pyran rings.
Tomography using x-ray transmission and a computer algorithm to reconstruct the image.
Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
A complication of kidney diseases characterized by cell death involving KIDNEY PAPILLA in the KIDNEY MEDULLA. Damages to this area may hinder the kidney to concentrate urine resulting in POLYURIA. Sloughed off necrotic tissue may block KIDNEY PELVIS or URETER. Necrosis of multiple renal papillae can lead to KIDNEY FAILURE.
A surgical specialty concerned with the study, diagnosis, and treatment of diseases of the urinary tract in both sexes, and the genital tract in the male. Common urological problems include urinary obstruction, URINARY INCONTINENCE, infections, and UROGENITAL NEOPLASMS.
A compound consisting of dark green crystals or crystalline powder, having a bronze-like luster. Solutions in water or alcohol have a deep blue color. Methylene blue is used as a bacteriologic stain and as an indicator. It inhibits GUANYLATE CYCLASE, and has been used to treat cyanide poisoning and to lower levels of METHEMOGLOBIN.
Procedures of applying ENDOSCOPES for disease diagnosis and treatment. Endoscopy involves passing an optical instrument through a small incision in the skin i.e., percutaneous; or through a natural orifice and along natural body pathways such as the digestive tract; and/or through an incision in the wall of a tubular structure or organ, i.e. transluminal, to examine or perform surgery on the interior parts of the body.
Involuntary loss of URINE, such as leaking of urine. It is a symptom of various underlying pathological processes. Major types of incontinence include URINARY URGE INCONTINENCE and URINARY STRESS INCONTINENCE.
Pathological processes of the VAGINA.
The middle germ layer of an embryo derived from three paired mesenchymal aggregates along the neural tube.
The space or compartment surrounded by the pelvic girdle (bony pelvis). It is subdivided into the greater pelvis and LESSER PELVIS. The pelvic girdle is formed by the PELVIC BONES and SACRUM.
An autosomal dominant disorder manifested by various combinations of preauricular pits, branchial fistulae or cysts, lacrimal duct stenosis, hearing loss, structural defects of the outer, middle, or inner ear, and renal dysplasia. Associated defects include asthenic habitus, long narrow facies, constricted palate, deep overbite, and myopia. Hearing loss may be due to Mondini type cochlear defect and stapes fixation. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed)
A non-fibrillar collagen found in BASEMENT MEMBRANE. The C-terminal end of the alpha1 chain of collagen type XVIII contains the ENDOSTATIN peptide, which can be released by proteolytic cleavage.
Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA).
Broadly distributed glycoproteins that are homologous to the activin-binding protein, FOLLISTATIN. These follistatin-related proteins are encoded by a number of genes.
Pathological processes of the KIDNEY or its component tissues.
The inferior and superior venae cavae.
Surgical union or shunt between ducts, tubes or vessels. It may be end-to-end, end-to-side, side-to-end, or side-to-side.
Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.
Elements of limited time intervals, contributing to particular results or situations.
A tube that transports URINE from the URINARY BLADDER to the outside of the body in both the sexes. It also has a reproductive function in the male by providing a passage for SPERM.
A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Application of a ligature to tie a vessel or strangulate a part.
The transference of a kidney from one human or animal to another.
A technique for maintenance or growth of animal organs in vitro. It refers to three-dimensional cultures of undisaggregated tissue retaining some or all of the histological features of the tissue in vivo. (Freshney, Culture of Animal Cells, 3d ed, p1)
The ability of the kidney to excrete in the urine high concentrations of solutes from the blood plasma.
A technetium diagnostic aid used in renal function determination.
A sucrose polymer of high molecular weight.
Inorganic salts of chloric acid that contain the ClO3- ion.
A potassium-channel opening vasodilator that has been investigated in the management of hypertension. It has also been tried in patients with asthma. (Martindale, The Extra Pharmacopoeia, 30th ed, p352)
A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.
The application of electronic, computerized control systems to mechanical devices designed to perform human functions. Formerly restricted to industry, but nowadays applied to artificial organs controlled by bionic (bioelectronic) devices, like automated insulin pumps and other prostheses.
The separation and isolation of tissues for surgical purposes, or for the analysis or study of their structures.
One or more layers of EPITHELIAL CELLS, supported by the basal lamina, which covers the inner or outer surfaces of the body.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
A mammalian neuropeptide of 10 amino acids that belongs to the tachykinin family. It is similar in structure and action to SUBSTANCE P and NEUROKININ B with the ability to excite neurons, dilate blood vessels, and contract smooth muscles, such as those in the BRONCHI.
A subtype of bone morphogenetic protein receptors with high affinity for BONE MORPHOGENETIC PROTEINS. They can interact with and undergo PHOSPHORYLATION by BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II. They signal primarily through RECEPTOR-REGULATED SMAD PROTEINS.
Incision into the side of the abdomen between the ribs and pelvis.
Complications that affect patients during surgery. They may or may not be associated with the disease for which the surgery is done, or within the same surgical procedure.
Devices that provide support for tubular structures that are being anastomosed or for body cavities during skin grafting.
A type of stress exerted uniformly in all directions. Its measure is the force exerted per unit area. (McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
The mechanical laws of fluid dynamics as they apply to urine transport.
An alkylamide found in CAPSICUM that acts at TRPV CATION CHANNELS.
An ergot derivative that is a congener of LYSERGIC ACID DIETHYLAMIDE. It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome.
A branch of the abdominal aorta which supplies the kidneys, adrenal glands and ureters.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
A bone morphogenetic protein that is a potent inducer of bone formation. It also functions as a regulator of MESODERM formation during EMBRYONIC DEVELOPMENT.
The distal and narrowest portion of the SMALL INTESTINE, between the JEJUNUM and the ILEOCECAL VALVE of the LARGE INTESTINE.
A technique that localizes specific nucleic acid sequences within intact chromosomes, eukaryotic cells, or bacterial cells through the use of specific nucleic acid-labeled probes.
Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.
An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
A family of intercellular signaling proteins that play and important role in regulating the development of many TISSUES and organs. Their name derives from the observation of a hedgehog-like appearance in DROSOPHILA embryos with genetic mutations that block their action.
Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions.
The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.
The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization).
Abrupt changes in the membrane potential that sweep along the CELL MEMBRANE of excitable cells in response to excitation stimuli.
Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.
The condition of an anatomical structure's being constricted beyond normal dimensions.
The relationship between the dose of an administered drug and the response of the organism to the drug.
The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)
Homopolymer of tetrafluoroethylene. Nonflammable, tough, inert plastic tubing or sheeting; used to line vessels, insulate, protect or lubricate apparatus; also as filter, coating for surgical implants or as prosthetic material. Synonyms: Fluoroflex; Fluoroplast; Ftoroplast; Halon; Polyfene; PTFE; Tetron.
Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites.
A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
A series of steps taken in order to conduct research.
Malformations of organs or body parts during development in utero.
Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells.
A noninvasive technique that uses the differential absorption properties of hemoglobin and myoglobin to evaluate tissue oxygenation and indirectly can measure regional hemodynamics and blood flow. Near-infrared light (NIR) can propagate through tissues and at particular wavelengths is differentially absorbed by oxygenated vs. deoxygenated forms of hemoglobin and myoglobin. Illumination of intact tissue with NIR allows qualitative assessment of changes in the tissue concentration of these molecules. The analysis is also used to determine body composition.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
Introduction of substances into the body using a needle and syringe.
The internal portion of the kidney, consisting of striated conical masses, the renal pyramids, whose bases are adjacent to the cortex and whose apices form prominent papillae projecting into the lumen of the minor calyces.
Drugs that selectively bind to and activate beta-adrenergic receptors.
A serotonin receptor subtype found widely distributed in peripheral tissues where it mediates the contractile responses of variety of tissues that contain SMOOTH MUSCLE. Selective 5-HT2A receptor antagonists include KETANSERIN. The 5-HT2A subtype is also located in BASAL GANGLIA and CEREBRAL CORTEX of the BRAIN where it mediates the effects of HALLUCINOGENS such as LSD.
The complex processes of initiating CELL DIFFERENTIATION in the embryo. The precise regulation by cell interactions leads to diversity of cell types and specific pattern of organization (EMBRYOGENESIS).
A trace element with atomic symbol Mn, atomic number 25, and atomic weight 54.94. It is concentrated in cell mitochondria, mostly in the pituitary gland, liver, pancreas, kidney, and bone, influences the synthesis of mucopolysaccharides, stimulates hepatic synthesis of cholesterol and fatty acids, and is a cofactor in many enzymes, including arginase and alkaline phosphatase in the liver. (From AMA Drug Evaluations Annual 1992, p2035)
Liquid by-product of excretion produced in the kidneys, temporarily stored in the bladder until discharge through the URETHRA.
The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed)
Ultrasonography applying the Doppler effect, with the superposition of flow information as colors on a gray scale in a real-time image. This type of ultrasonography is well-suited to identifying the location of high-velocity flow (such as in a stenosis) or of mapping the extent of flow in a certain region.
Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions.
A family of seven-pass transmembrane cell-surface proteins that combines with LOW DENSITY LIPROTEIN RECEPTOR-RELATED PROTEIN-5 or LOW DENSITY LIPROTEIN RECEPTOR-RELATED PROTEIN-5 to form receptors for WNT PROTEINS. Frizzled receptors often couple with HETEROTRIMERIC G PROTEINS and regulate the WNT SIGNALING PATHWAY.
An inhibitor of nitric oxide synthetase which has been shown to prevent glutamate toxicity. Nitroarginine has been experimentally tested for its ability to prevent ammonia toxicity and ammonia-induced alterations in brain energy and ammonia metabolites. (Neurochem Res 1995:200(4):451-6)
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
One of a pair of thick-walled tubes that transports urine from the KIDNEY PELVIS to the URINARY BLADDER.
A fibroblast growth factor that is a mitogen for KERATINOCYTES. It activates FIBROBLAST GROWTH FACTOR RECEPTOR 2B and is involved in LUNG and limb development.
Bone-growth regulatory factors that are members of the transforming growth factor-beta superfamily of proteins. They are synthesized as large precursor molecules which are cleaved by proteolytic enzymes. The active form can consist of a dimer of two identical proteins or a heterodimer of two related bone morphogenetic proteins.
An aminoperhydroquinazoline poison found mainly in the liver and ovaries of fishes in the order TETRAODONTIFORMES, which are eaten. The toxin causes paresthesia and paralysis through interference with neuromuscular conduction.
Use of electric potential or currents to elicit biological responses.
Wnt proteins are a large family of secreted glycoproteins that play essential roles in EMBRYONIC AND FETAL DEVELOPMENT, and tissue maintenance. They bind to FRIZZLED RECEPTORS and act as PARACRINE PROTEIN FACTORS to initiate a variety of SIGNAL TRANSDUCTION PATHWAYS. The canonical Wnt signaling pathway stabilizes the transcriptional coactivator BETA CATENIN.
Angiostatic proteins that are formed from proteolytic cleavage of COLLAGEN TYPE XVIII.
A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen.
An individual that contains cell populations derived from different zygotes.
Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs.
Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.
A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
Treatment process involving the injection of fluid into an organ or tissue.
Developmental events leading to the formation of adult muscular system, which includes differentiation of the various types of muscle cell precursors, migration of myoblasts, activation of myogenesis and development of muscle anchorage.
An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.
The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.
Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project.
Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
That phase of a muscle twitch during which a muscle returns to a resting position.
A constitutively-expressed subtype of prostaglandin-endoperoxide synthase. It plays an important role in many cellular processes.
Cell membrane glycoproteins that are selectively permeable to potassium ions. At least eight major groups of K channels exist and they are made up of dozens of different subunits.
A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Neurons which conduct NERVE IMPULSES to the CENTRAL NERVOUS SYSTEM.
A non-steroidal anti-inflammatory agent (NSAID) that inhibits the enzyme cyclooxygenase necessary for the formation of prostaglandins and other autacoids. It also inhibits the motility of polymorphonuclear leukocytes.
A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA.
Azoles of one NITROGEN and two double bonds that have aromatic chemical properties.
The species Oryctolagus cuniculus, in the family Leporidae, order LAGOMORPHA. Rabbits are born in burrows, furless, and with eyes and ears closed. In contrast with HARES, rabbits have 22 chromosome pairs.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS.
Factors which enhance the growth potentialities of sensory and sympathetic nerve cells.
Non-human animals, selected because of specific characteristics, for use in experimental research, teaching, or testing.
Proteins encoded by homeobox genes (GENES, HOMEOBOX) that exhibit structural similarity to certain prokaryotic and eukaryotic DNA-binding proteins. Homeodomain proteins are involved in the control of gene expression during morphogenesis and development (GENE EXPRESSION REGULATION, DEVELOPMENTAL).
Filamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments (known also as filamentous or F-actin) can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-actin. In conjunction with MYOSINS, actin is responsible for the contraction and relaxation of muscle.
The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.
Infections with bacteria of the species ESCHERICHIA COLI.

Stromal cells mediate retinoid-dependent functions essential for renal development. (1/868)

The essential role of vitamin A and its metabolites, retinoids, in kidney development has been demonstrated in vitamin A deficiency and gene targeting studies. Retinoids signal via nuclear transcription factors belonging to the retinoic acid receptor (RAR) and retinoid X receptor (RXR) families. Inactivation of RARaplpha and RARbeta2 receptors together, but not singly, resulted in renal malformations, suggesting that within a given renal cell type, their concerted function is required for renal morphogenesis. At birth, RARalpha beta2(-) mutants displayed small kidneys, containing few ureteric bud branches, reduced numbers of nephrons and lacking the nephrogenic zone where new nephrons are continuously added. These observations have prompted us to investigate the role of RARalpha and RARbeta2 in renal development in detail. We have found that within the embryonic kidney, RARalpha and RARbeta2 are colocalized in stromal cells, but not in other renal cell types, suggesting that stromal cells mediate retinoid-dependent functions essential for renal development. Analysis of RARalpha beta2(-) mutant kidneys at embryonic stages revealed that nephrons were formed and revealed no changes in the intensity or distribution of molecular markers specific for different metanephric mesenchymal cell types. In contrast the development of the collecting duct system was greatly impaired in RARalpha beta2(-) mutant kidneys. Fewer ureteric bud branches were present, and ureteric bud ends were positioned abnormally, at a distance from the renal capsule. Analysis of genes important for ureteric bud morphogenesis revealed that the proto-oncogene c-ret was downregulated. Our results suggest that RARalpha and RARbeta2 are required for generating stromal cell signals that maintain c-ret expression in the embryonic kidney. Since c-ret signaling is required for ureteric bud morphogenesis, loss of c-ret expression is a likely cause of impaired ureteric bud branching in RARalpha beta2(-) mutants.  (+info)

Observations on some additional abnormalities in situs inversus viscerum. (2/868)

The abnormal findings in a case of Situs inversus totalis are described. The duodenum was placed abnormally and retained its primitive mesentery. The proximal 22 in of jejunum were retroperitoneal. The attachment of the root of the mesentery to the posterior abdominal wall had a 7-shaped appearance, and there was a partial failure of the primitive mesocolon to adhere to the posterior abdominal wall. The common hepatic artery arose from the superior meseneric artery, which also provided a branch to the proximal jejunal loop. The right vagus nerve was found anterior to the oesophagus at the oesophageal hiatus in the diaphragm, and the left vagus was posterior. A double ureter was present on the right side. The findings are discussed in relation to mid-gut development.  (+info)

Dominant effects of RET receptor misexpression and ligand-independent RET signaling on ureteric bud development. (3/868)

During kidney development, factors from the metanephric mesenchyme induce the growth and repeated branching of the ureteric bud, which gives rise to the collecting duct system and also induces nephrogenesis. One signaling pathway known to be required for this process includes the receptor tyrosine kinase RET and co-receptor GFR(&agr;)-1, which are expressed in the ureteric bud, and the secreted ligand GDNF produced in the mesenchyme. To examine the role of RET signaling in ureteric bud morphogenesis, we produced transgenic mice in which the pattern of RET expression was altered, or in which a ligand-independent form of RET kinase was expressed. The Hoxb7 promoter was used to express RET throughout the ureteric bud branches, in contrast to its normal expression only at the bud tips. This caused a variable inhibition of ureteric bud growth and branching reminiscent of, but less severe than, the RET knockout phenotype. Manipulation of the level of GDNF, in vitro or in vivo, suggested that this defect was due to insufficient rather than excessive RET signaling. We propose that RET receptors expressed ectopically on ureteric bud trunk cells sequester GDNF, reducing its availability to the normal target cells at the bud tips. When crossed to RET knockout mice, the Hoxb7/RET transgene, which encoded the RET9 isoform, supported normal kidney development in some RET-/- animals, indicating that the other major isoform, RET51, is not required in this organ. Expression of a Hoxb7/RET-PTC2 transgene, encoding a ligand-independent form of RET kinase, caused the development of abnormal nodules, outside the kidney or at its periphery, containing branched epithelial tubules apparently formed by deregulated growth of the ureteric bud. This suggests that RET signaling is not only necessary but is sufficient to induce ureteric bud growth, and that the orderly, centripetal growth of the bud tips is controlled by the spatially and temporally regulated expression of GDNF and RET.  (+info)

A2B adenosine receptors mediate relaxation of the pig intravesical ureter: adenosine modulation of non adrenergic non cholinergic excitatory neurotransmission. (4/868)

1. The present study was designed to characterize the adenosine receptors involved in the relaxation of the pig intravesical ureter, and to investigate the action of adenosine on the non adrenergic non cholinergic (NANC) excitatory ureteral neurotransmission. 2. In U46619 (10(-7) M)-contracted strips treated with the adenosine uptake inhibitor, nitrobenzylthioinosine (NBTI, 10(-6) M), adenosine and related analogues induced relaxations with the following potency order: 5'-N-ethylcarboxamidoadenosine (NECA) = 5'-(N-cyclopropyl)-carboxamidoadenosine (CPCA) = 2-chloroadenosine (2-CA) > adenosine > cyclopentyladenosine (CPA) = N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide (IB-MECA) = 2-[p-(carboxyethyl)-phenylethylamino]-5'-N-ethylcarboxamidoaden os ine (CGS21680). 3. Epithelium removal or incubation with indomethacin (3 x 10(-6) M) and L-N(G)-nitroarginine (L-NOARG, 3 x 10(-5) M), inhibitors of prostanoids and nitric oxide (NO) synthase, respectively, failed to modify the relaxations to adenosine. 4. 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 10(-8) M) and 4-(2-[7-amino-2-(2-furyl) [1,2,4]-triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol (ZM 241385, 3 x 10(-8) M and 10(-7) M), A1 and A2A receptor selective antagonists, respectively, did not modify the relaxations to adenosine or NECA. 8-phenyltheophylline (8-PT, 10(-5) M) and DPCPX (10(-6) M), which block A1/A2-receptors, reduced such relaxations. 5. In strips treated with guanethidine (10(-5) M), atropine (10(-7) M), L-NOARG (3 x 10(-5) M) and indomethacin (3 x 10(-6) M), both electrical field stimulation (EFS, 5 Hz) and exogenous ATP (10(-4) M) induced contractions of preparations. 8-PT (10(-5) M) increased both contractions. DPCPX (10(-8) M), NECA (10(-4) M), CPCA, (10(-4) M) and 2-CA (10(-4) M) did not alter the contractions to EFS. 6. The present results suggest that adenosine relaxes the pig intravesical ureter, independently of prostanoids or NO, through activation of A2B-receptors located in the smooth muscle. This relaxation may modulate the ureteral NANC excitatory neurotransmission through a postsynaptic mechanism.  (+info)

Vesicoureteral reflux in male and female neonates as detected by voiding ultrasonography. (5/868)

BACKGROUND: Vesicoureteral reflux (VUR) is assumed to be congenital, and its early diagnosis is desired in order to prevent acquired renal damage. However, the incidence of VUR in neonates remains to be revealed. METHODS: Two thousand newborn babies (1048 boys and 952 girls) underwent voiding ultrasonography (an ultrasound examination of urinary tract during provoked voiding). Those who showed transient renal pelvic dilation during voiding, who had small kidneys, or who subsequently developed urinary infection underwent voiding cystourethrography. RESULTS: Transient renal pelvic dilation was observed in 16 babies (0.8%), including one boy with small kidneys. Among the rest of the babies, one boy had a small kidney, and nine babies subsequently developed urinary infection. Voiding cystourethrography revealed VUR in 24 ureters of 16 children (11 boys and 5 girls). Dimercaptosuccinate renoscintigraphy confirmed small kidneys, with generally reduced tracer uptake in a total of three boys, all having VUR. Voiding ultrasonography detected transient renal pelvic dilation in 17 (71%) of the 24 kidneys with VUR and, strikingly, 16 of the 17 (94%) kidneys with high-grade VUR (grade III or more). CONCLUSION: This study effectively detected VUR in 0.8% of the neonates (mostly of high grades and predominantly in males) and voiding ultrasonography showed a decided usefulness for the detection of VUR. The male preponderance of VUR in neonates was considered to be due to the occurrence of congenitally small kidneys, with reflux found exclusively in males and easier ultrasound detection of VUR in male neonates because the majority of diagnoses are reported to be high grades of VUR.  (+info)

Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros. (6/868)

Development of the embryonic kidney results from reciprocal signaling between the ureteric bud and the metanephric mesenchyme. To identify the signaling molecules, we developed an assay in which metanephric mesenchymes are rescued from apoptosis by factors secreted from ureteric bud cells (UB cells). Purification and sequencing of one such factor identified the tissue inhibitor of metalloproteinase-2 (TIMP-2) as a metanephric mesenchymal growth factor. Growth activity was unlikely due to TIMP-2 inhibition of matrix metalloproteinases because ilomastat, a synthetic inhibitor of these enzymes, had no mesenchymal growth action. TIMP-2 was also involved in morphogenesis of the ureteric bud, inhibiting its branching and changing the deposition of its basement membrane; these effects were due to TIMP-2 inhibition of matrix metalloproteinases, as they were reproduced by ilomastat. Thus, TIMP-2 regulates kidney development by at least 2 distinct mechanisms. In addition, TIMP-2 was secreted from UB cells by mesenchymal factors that are essential for ureteric bud development. Hence, the mesenchyme synchronizes its own growth with ureteric morphogenesis by stimulating the secretion of TIMP-2 from the ureteric bud.  (+info)

The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy. (7/868)

BACKGROUND: Inhibition of angiotensin action, pharmacologically or genetically, during the neonatal period leads to renal anomalies involving hypoplastic papilla and dilated calyx. Recently, we documented that angiotensinogen (Agt -/-) or angiotensin type 1 receptor nullizygotes (Agtr1 -/-) do not develop renal pelvis nor ureteral peristaltic movement, both of which are essential for isolating the kidney from the high downstream ureteral pressure. We therefore examined whether these renal anomalies could be characterized as "obstructive" nephropathy. METHODS: Agtr1 -/- neonatal mice were compared with wild-type neonates, the latter subjected to surgical complete unilateral ureteral ligation (UUO), by analyzing morphometrical, immunohistochemical, and molecular indices. Agtr1 -/- mice were also subjected to a complete UUO and were compared with wild-type UUO mice by quantitative analysis. To assess the function of the urinary tract, baseline pelvic and ureteral pressures were measured. RESULTS: The structural anomalies were qualitatively indistinguishable between the Agtr1 -/- without surgical obstruction versus the wild type with complete UUO. Thus, in both kidneys, the calyx was enlarged, whereas the papilla was atrophic; tubulointerstitial cells underwent proliferation and also apoptosis. Both were also characterized by interstitial macrophage infiltration and fibrosis, and within the local lesion, transforming growth factor-beta 1, platelet-derived growth factor-A and insulin-like growth factor-1 were up-regulated, whereas epidermal growth factor was down-regulated. Moreover, quantitative differences that exist between mutant kidneys without surgical obstruction and wild-type kidneys with surgical UUO were abolished when both underwent the same complete surgical UUO. The hydraulic baseline pressure was always lower in the pelvis than that in the ureter in the wild type, whereas this pressure gradient was reversed in the mutant. CONCLUSION: The abnormal kidney structure that develops in neonates during angiotensin inhibition is attributed largely to "functional obstruction" of the urinary tract caused by the defective development of peristaltic machinery.  (+info)

The effect of cyclopiazonic acid on excitation-contraction coupling in guinea-pig ureteric smooth muscle: role of the sarcoplasmic reticulum. (8/868)

1. We have investigated the effect of cyclopiazonic acid (CPA), an inhibitor of the sarcoplasmic reticulum (SR) Ca2+-ATPase on excitation-contraction (EC) coupling in guinea-pig ureter, by measuring membrane currents, action potentials, intracellular [Ca2+] and force. 2. CPA (20 micrometers) significantly enhanced the amplitude and duration of phasic contractions of ureteric smooth muscle associated with action potentials. This was accompanied by an increase in the duration of the intracellular Ca2+ transient in intact tissue and single cells but not their amplitude. However, CPA also slowed the rate of rise, and fall, of the force 1|1|Phiand1Phi Ca2+ transients. 3. Membrane potential recordings showed that CPA produced a small depolarization and a large increase in the duration of the plateau phase of the action potential. 4. Patch-clamp studies showed marked inhibition of outward potassium current in the presence of CPA and an inhibition of spontaneous transient outward currents (STOCs). CPA had no effect on inward Ca2+ current. 5. These data suggest that the SR plays a major role in modulating the excitability of the ureter, particularly via curtailing the action potential duration. This in turn will shorten the Ca2+ transient and decrease force. This negative action on developed force predominates over any small role it may play in initiating force in the guinea-pig ureter.  (+info)

1. Ureteral stones: Small, hard mineral deposits that form in the ureters and can cause pain, bleeding, and blockage of urine flow.
2. Ureteral tumors: Abnormal growths that can be benign or cancerous and can cause symptoms such as blood in the urine, pain, and difficulty urinating.
3. Ureteral strictures: Narrowing of the ureters due to scarring or inflammation, which can cause pain and blockage of urine flow.
4. Ureteral injuries: Trauma to the ureters during surgery or other medical procedures can cause damage and lead to ureteral diseases.
5. Ureteral ectopia: A rare condition in which the ureters do not properly connect to the bladder, leading to urine leakage and other symptoms.
6. Ureteral tuberculosis: A type of bacterial infection that affects the ureters and can cause symptoms such as fever, weight loss, and blood in the urine.
7. Ureteral cancer: Cancer that affects the ureters and can cause symptoms such as blood in the urine, pain, and difficulty urinating.
8. Ureteral calculus: A small, hard deposit that forms in the ureters and can cause pain, bleeding, and blockage of urine flow.
9. Ureteral stenosis: A narrowing of the ureters due to scarring or inflammation, which can cause pain and blockage of urine flow.
10. Ureteral obstruction: A blockage of the ureters that can be caused by a variety of factors, such as tumors, stones, or inflammation.

Ureteral diseases can be diagnosed through a combination of physical examination, imaging studies such as X-rays and CT scans, and endoscopic procedures such as ureteroscopy. Treatment options vary depending on the specific condition and may include antibiotics, surgery, or other interventions to address the underlying cause of the disease. It is important to seek medical attention if symptoms persist or worsen over time, as early diagnosis and treatment can help prevent complications and improve outcomes.

Symptoms of hydronephrosis may include flank pain, nausea, vomiting, fever, and blood in the urine. If left untreated, hydronephrosis can lead to kidney damage and even failure. Treatment for hydronephrosis typically involves relieving the obstruction and addressing any underlying causes. In some cases, surgery may be necessary to repair damaged tissue or remove blockages.

Hydronephrosis is a serious medical condition that requires prompt medical attention to prevent complications and preserve kidney function. It is important to seek medical care if symptoms of hydronephrosis are present, as early diagnosis and treatment can improve outcomes.

Treatment for ureteral obstruction depends on the underlying cause and may include medications, endoscopic procedures, or surgery. In some cases, a temporary drainage catheter may be placed in the ureter to help relieve symptoms until the blockage can be fully treated.

Ureteral obstruction can be acute or chronic, and may occur in adults or children. It is important to seek medical attention if symptoms persist or worsen over time, as untreated ureteral obstruction can lead to complications such as kidney damage or sepsis.

Causes of Ureteral Obstruction:

Ureteral obstruction can be caused by a variety of factors, including:

1. Kidney stones: Small, hard mineral deposits that form in the urine and can block the flow of urine through the ureters.
2. Tumors: Cancerous or non-cancerous growths that can block the ureters.
3. Scar tissue: Scarring from previous surgeries or injuries can cause narrowing or blockages in the ureters.
4. Prostate enlargement: In men, an enlarged prostate gland can press on the urethra and ureters, causing blockages.
5. Bladder neck obstruction: A condition where the bladder neck is narrow or blocked, preventing urine from flowing through the urethra.
6. Trauma: Injuries to the ureters or bladder can cause blockages.
7. Inflammation: Inflammation in the ureters or kidneys can cause swelling and blockages.
8. Congenital conditions: Some people may be born with abnormalities that cause blockages in the urinary tract.
9. Neurological disorders: Conditions such as multiple sclerosis, Parkinson's disease, or spinal cord injuries can affect the nerves that control the bladder and ureters, leading to blockages.
10. Medications: Certain medications, such as certain antibiotics and chemotherapy drugs, can cause damage to the ureters and lead to blockages.

There are several types of ureteral calculi, including:

1. Calcium oxalate stones: These are the most common type of ureteral calculus and are formed from a combination of calcium and oxalate in the urine.
2. Uric acid stones: These stones are formed when there is an excess of uric acid in the urine, often as a result of certain medical conditions such as gout or kidney disease.
3. Cystine stones: These stones are formed from the amino acid cystine and are rare.
4. Struvite stones: These stones are formed from magnesium and ammonium and are usually associated with urinary tract infections.

The symptoms of ureteral calculi can vary depending on the size and location of the stone, but may include:

1. Severe pain in the side or back, below the ribs
2. Pain that radiates to the lower abdomen or groin
3. Nausea and vomiting
4. Frequent or painful urination
5. Blood in the urine
6. Fever and chills
7. Cloudy or strong-smelling urine

Ureteral calculi are usually diagnosed with a combination of imaging tests such as X-rays, CT scans, or ultrasound, and laboratory tests to determine the presence of stones and rule out other conditions. Treatment options for ureteral calculi depend on the size and location of the stone, but may include:

1. Watchful waiting: Small stones may pass on their own without treatment.
2. Medications: Alpha-blockers or potassium citrate can be used to help manage symptoms and pass larger stones.
3. Shock wave lithotripsy: A non-invasive procedure that uses shock waves to break up the stone into smaller pieces that can be passed more easily.
4. Ureteroscopy: A minimally invasive procedure in which a scope is inserted through the urethra and bladder to remove the stone.
5. Percutaneous nephrolithotomy: A more invasive procedure in which a small incision is made in the back to remove the stone.

It is important to seek medical attention if symptoms persist or worsen over time, as ureteral calculi can lead to complications such as urinary tract infections, kidney damage, or blockage of the urinary tract.

VUR occurs when the muscles in the ureteral walls are weak or underdeveloped, allowing urine to flow back into the bladder instead of emptying properly into the ureters. It can also be caused by an abnormal connection between the bladder and the ureter, such as a birth defect or injury.

Symptoms of VUR may include recurring UTIs, fever, painful urination, and blood in the urine. To diagnose VUR, doctors may use imaging tests such as ultrasound or renal scan to visualize the flow of urine.

Treatment for VUR depends on the severity of the condition and may include antibiotics to treat UTIs, medication to relax the bladder muscle, and in some cases, surgery to repair any abnormal connections or narrowing of the ureters.

The symptoms of urinary fistula can vary depending on the location and severity of the condition, but may include:

* Incontinence or leakage of urine
* Pain or discomfort in the abdomen or pelvis
* Frequent urination or difficulty starting a stream of urine
* Blood in the urine
* Cloudy or strong-smelling urine
* Recurring urinary tract infections

Treatment for urinary fistula typically involves surgery to repair the abnormal connection and restore normal urinary function. In some cases, this may involve creating a new opening for urine to pass through or repairing damaged tissue.

Preventive measures for urinary fistula are not well established, but good hygiene practices and proper care after surgery can help reduce the risk of developing the condition. Early detection and treatment are important to prevent complications and improve outcomes.

Symptoms of ureterocele may include:

* Pain in the flank or lower abdomen
* Blood in the urine
* Frequent urination
* Difficulty starting a stream of urine
* Increased urgency to urinate

Diagnosis is typically made with ultrasound, voiding cystourethrogram (VCUG), or other imaging studies. Treatment options may include:

* Endoscopic therapy, such as ureteral dilation or stent placement
* Open surgery to repair the ureterocele and any associated structural issues

Prognosis is generally good if treated early, but complications can include chronic kidney disease, urinary tract infections, and other long-term effects.

Transitional cell carcinoma typically affects older adults, with the average age at diagnosis being around 70 years. Men are more likely to be affected than women, and the risk of developing TCC increases with age and exposure to certain environmental factors such as smoking and exposure to certain chemicals.

The symptoms of TCC can vary depending on the location and stage of the cancer, but may include:

* Blood in the urine (hematuria)
* Painful urination
* Frequent urination
* Pain in the lower abdomen or back

If left untreated, TCC can spread to other parts of the body, including the lymph nodes, liver, and bones. Treatment options for TCC may include surgery, chemotherapy, and immunotherapy, and the prognosis depends on the stage and location of the cancer at the time of diagnosis.

Preventive measures to reduce the risk of developing TCC include maintaining a healthy diet and lifestyle, avoiding smoking and excessive alcohol consumption, and regular screening for bladder cancer. Early detection and treatment can improve the prognosis for patients with TCC.

Types of Urinary Calculi:

1. Calcium oxalate stones: These are the most common type of kidney stone and are often caused by excess calcium and oxalate in the urine.
2. Uric acid stones: These stones are often associated with gout or a diet high in meat and seafood.
3. Cystine stones: These stones are rare and usually occur in people with a genetic disorder that affects the transport of cystine in the kidneys.
4. Struvite stones: These stones are often associated with urinary tract infections.

Causes and Risk Factors:

1. Dehydration: Not drinking enough water can cause a decrease in urine production, which can increase the concentration of minerals in the urine and increase the risk of stone formation.
2. Diet: A diet high in animal protein, sodium, and sugar can increase the risk of stone formation.
3. Medical conditions: Certain medical conditions such as gout, kidney disease, and inflammatory bowel disease can increase the risk of developing urinary calculi.
4. Genetics: A family history of kidney stones can increase an individual's risk.
5. Other factors: Other factors that can increase the risk of developing urinary calculi include a high body mass index (BMI), a sedentary lifestyle, and certain medications such as certain antibiotics and diuretics.

Symptoms:

1. Severe pain in the side or back, below the ribs
2. Pain that radiates to the lower abdomen or groin
3. Nausea and vomiting
4. Blood in the urine (hematuria)
5. Cloudy or strong-smelling urine
6. Frequent urination or a burning sensation during urination

Diagnosis:

1. Medical history and physical examination
2. Urinalysis to check for blood, protein, and white blood cells in the urine
3. Imaging tests such as X-rays, CT scans, or ultrasound to confirm the presence of calculi
4. Laboratory tests to check for underlying medical conditions such as kidney disease or infection

Treatment:

1. Drinking plenty of water to help flush out small calculi
2. Pain management with medication
3. Medical expulsive therapy with medication to help pass larger calculi
4. Shock wave lithotripsy to break down larger calculi into smaller pieces that can be passed more easily
5. Surgery to remove large or unbreakable calculi

Prevention:

1. Drinking plenty of water to stay hydrated and help prevent the formation of calculi
2. Limiting the intake of animal protein, sodium, and sugar
3. Managing underlying medical conditions such as gout, kidney disease, and inflammatory bowel disease
4. Maintaining a healthy weight and exercise regularly
5. Avoiding certain medications that can increase the risk of calculus formation.

Some common types of urologic neoplasms include:

1. Renal cell carcinoma (RCC): a type of kidney cancer that originates in the cells of the kidney's tubules.
2. Bladder cancer: a type of cancer that affects the cells lining the bladder, and can be classified as superficial or invasive.
3. Ureteral cancer: a rare type of cancer that develops in the muscular tissue of the ureters.
4. Prostate cancer: a common type of cancer in men that affects the prostate gland.
5. Penile cancer: a rare type of cancer that develops on the penis, usually in the skin or mucous membranes.
6. Testicular cancer: a rare type of cancer that develops in the testicles, and is most common in young men between the ages of 15 and 35.

The symptoms of urologic neoplasms can vary depending on their location and size, but may include blood in the urine, painful urination, frequent urination, or abdominal pain. Diagnosis is typically made through a combination of imaging studies (such as CT scans or ultrasound) and tissue biopsy.

Treatment options for urologic neoplasms vary depending on the type, size, location, and stage of the tumor, but may include surgery, chemotherapy, radiation therapy, or a combination of these. In some cases, watchful waiting or active surveillance may be recommended for small, slow-growing tumors that are not causing symptoms or threatening the patient's life.

The prognosis for urologic neoplasms varies depending on the type and stage of the cancer at the time of diagnosis. In general, early detection and treatment improve the chances of a successful outcome. However, some types of urologic neoplasms are more aggressive and difficult to treat than others.

Prevention is often challenging for urologic neoplasms, as many risk factors (such as family history or genetic predisposition) cannot be controlled. However, some measures may help reduce the risk of developing certain types of urologic neoplasms, such as:

* Maintaining a healthy diet and lifestyle
* Avoiding smoking and excessive alcohol consumption
* Protecting the skin from sun exposure to reduce the risk of skin cancer
* Avoiding exposure to certain chemicals or toxins that may increase the risk of certain types of cancer
* Practicing safe sex to reduce the risk of HPV-related cancers.

Some common symptoms of dysuria include:

* Pain or burning sensation while urinating
* Frequent urination
* Cloudy or strong-smelling urine
* Blood in the urine
* Abdominal pain

If you are experiencing any of these symptoms, it is important to seek medical attention as soon as possible. A healthcare professional can diagnose the underlying cause of your dysuria and provide appropriate treatment.

Treatment for dysuria will depend on the underlying cause of the condition. For example, if your dysuria is caused by a UTI, antibiotics may be prescribed to treat the infection. If the condition is caused by a kidney stone, you may need to undergo surgery or other procedures to remove the stone.

In addition to medical treatment, there are some home remedies that can help alleviate the symptoms of dysuria. These include:

* Drinking plenty of water to flush out bacteria and other harmful substances from your urinary system
* Urinating when you feel the need, rather than holding it in
* Applying a warm compress to your lower abdomen to help soothe the pain
* Avoiding certain foods that may irritate your bladder, such as spicy or acidic foods.

It is important to note that dysuria can be a symptom of a more serious underlying condition, so it is important to seek medical attention if you experience any of the symptoms for an extended period of time or if they are severe. With proper treatment and self-care, however, most people with dysuria can find relief from their symptoms and improve their overall health.

There are several types of kidney calculi, including:

1. Calcium oxalate calculi: These are the most common type of calculus and are often associated with conditions such as hyperparathyroidism or excessive intake of calcium supplements.
2. Uric acid calculi: These are more common in people with gout or a diet high in meat and sugar.
3. Cystine calculi: These are rare and usually associated with a genetic disorder called cystinuria.
4. Struvite calculi: These are often seen in women with urinary tract infections (UTIs).

Symptoms of kidney calculi may include:

1. Flank pain (pain in the side or back)
2. Pain while urinating
3. Blood in the urine
4. Cloudy or strong-smelling urine
5. Fever and chills
6. Nausea and vomiting

Kidney calculi are diagnosed through a combination of physical examination, medical history, and diagnostic tests such as X-rays, CT scans, or ultrasound. Treatment options for kidney calculi depend on the size and location of the calculus, as well as the severity of any underlying conditions. Small calculi may be treated with conservative measures such as fluid intake and medication to help flush out the crystals, while larger calculi may require surgical intervention to remove them.

Preventive measures for kidney calculi include staying hydrated to help flush out excess minerals in the urine, maintaining a balanced diet low in oxalate and animal protein, and avoiding certain medications that can increase the risk of calculus formation. Early detection and treatment of underlying conditions such as hyperparathyroidism or gout can also help prevent the development of kidney calculi.

Overall, kidney calculi are a common condition that can be managed with proper diagnosis and treatment. However, they can cause significant discomfort and potentially lead to complications if left untreated, so it is important to seek medical attention if symptoms persist or worsen over time.

The exact cause of RPF is not known, but it is believed to be related to inflammation or injury to the retroperitoneal tissues. The condition can occur at any age but is more common in adults between 30 and 60 years old.

Symptoms of RPF may include:

1. Back pain
2. Pain in the flank or abdomen
3. Weight loss
4. Fatigue
5. High blood pressure
6. Hematuria (blood in the urine)
7. Proteinuria (excess protein in the urine)
8. Kidney dysfunction

Diagnosis of RPF is based on a combination of imaging studies, such as CT or MRI scans, and a biopsy, which involves removing a small sample of tissue from the retroperitoneum for examination under a microscope.

Treatment options for RPF depend on the severity of the condition and may include:

1. Observation: In some cases, the condition may be monitored with regular imaging studies to see if it progresses or resolves over time.
2. Steroids: Corticosteroids may be prescribed to reduce inflammation and slow the growth of fibrous tissue.
3. Immunosuppressive medications: Medications that suppress the immune system, such as cyclosporine or tacrolimus, may be used to treat RPF if it is thought to be caused by an abnormal immune response.
4. Surgery: In some cases, surgery may be necessary to remove the fibrous tissue and repair any damage to the kidneys or other structures in the retroperitoneal space.
5. Radiation therapy: Radiation therapy may be used in combination with chemotherapy to treat RPF that is caused by cancer.
6. Chemotherapy: Chemotherapy may be used in combination with radiation therapy to treat RPF that is caused by cancer.
7. Embolization: Embolization is a minimally invasive procedure in which a catheter is inserted into the hepatic artery and embolized particles are injected to block the blood flow to the tumor, this can be used to shrink the tumor before surgery or radiation therapy.
8. Targeted therapy: Targeted therapy may be used in some cases of RPF that is caused by cancer, such as using bevacizumab to target vascular endothelial growth factor (VEGF) which is a protein that promotes angiogenesis.

It's important to note that the most effective treatment approach will depend on the specific cause of RPF, and the patient's overall health status and medical history. A multidisciplinary team of healthcare professionals, including a nephrologist, oncologist, radiologist, and surgeon, should be involved in the treatment planning and decision-making process.

MCDK is thought to be caused by genetic mutations that disrupt the normal development of the kidneys during fetal development. The exact cause of the condition is not well understood, but it is believed to be more common in children with a family history of the disorder or other congenital anomalies.

Symptoms of MCDK may include:

* Abnormal urinary tract anatomy
* Kidney damage or failure
* High blood pressure
* Proteinuria (excess protein in the urine)
* Hematuria (blood in the urine)

If you suspect that your child may have MCDK, it is important to consult a healthcare provider as soon as possible. A diagnosis of MCDK can be made through ultrasound examination, kidney biopsy, or other imaging tests.

There is no cure for MCDK, but treatment options are available to manage the symptoms and slow the progression of the disease. These may include:

* Regular monitoring of blood pressure and urine output
* Medications to control high blood pressure and proteinuria
* Dietary modifications to reduce protein intake and increase fluid intake
* Surgery to repair or remove damaged kidney tissue

The prognosis for children with MCDK varies depending on the severity of the condition and the presence of any other underlying health issues. In some cases, MCDK may progress to end-stage renal disease (ESRD), which requires dialysis or a kidney transplant. However, with early detection and appropriate management, many children with MCDK can lead normal, healthy lives.

In the medical field, "vaginal fistula" is a term that is used to describe an abnormal connection between two organs or between an organ and the skin that occurs in the vagina. This condition can have a significant impact on a woman's quality of life, causing a range of symptoms such as urinary incontinence, vaginal discharge, pain during intercourse, and pelvic pressure.

The causes of vaginal fistula can be varied and may include:

* Childbirth: Vaginal tears or episiotomy during delivery can sometimes lead to a fistula.
* Sexual trauma: Traumatic sexual experiences, such as rape or sexual assault, can cause a fistula to develop.
* Radiation therapy: Radiation therapy to the pelvic area can damage the vaginal tissue and lead to a fistula.
* Surgery: Certain surgeries, such as hysterectomy or bladder neck suspension, can sometimes result in a fistula.

Treatment options for vaginal fistula depend on the underlying cause and the severity of the condition. Surgery is often the primary treatment approach, and may involve repairing or closing the fistula, or removing any damaged tissue. Hormonal therapy may also be prescribed to help manage symptoms such as vaginal dryness or pain during intercourse. Other supportive measures, such as catheterization or urethral dilatation, may also be necessary to help manage urinary incontinence or other complications.

In summary, vaginal fistula is a condition that can cause significant distress and disrupt daily life. It is important to seek medical attention if symptoms persist or worsen over time, as early diagnosis and treatment can improve outcomes and reduce the risk of long-term complications.

Examples of Urogenital Abnormalities:

1. Congenital Anomalies: Conditions that are present at birth and affect the urinary tract or genitalia, such as hypospadias (a condition where the urethra opens on the underside of the penis instead of the tip), undescended testes (testes that fail to descend into the scrotum), or interrupted or absent vas deferens (tubes that carry sperm from the epididymis to the penis).
2. Infections: Bacterial or viral infections that can cause urogenital abnormalities, such as pyelonephritis (a kidney infection) or prostatitis (an inflammation of the prostate gland).
3. Trauma: Injuries to the urinary tract or genitalia, such as those caused by sexual assault or accidents, can lead to urogenital abnormalities.
4. Neurological Conditions: Certain neurological conditions, such as spina bifida (a birth defect that affects the spine and spinal cord), can cause urogenital abnormalities.
5. Cancer: Cancer of the urinary tract or genitalia, such as bladder cancer or prostate cancer, can cause urogenital abnormalities.

Symptoms of Urogenital Abnormalities:

Depending on the specific condition, symptoms of urogenital abnormalities may include:

1. Difficulty urinating or painful urination
2. Blood in the urine or semen
3. Frequent urination or incontinence
4. Pain during sexual activity
5. Abnormalities in the shape or size of the genitalia
6. Testicular atrophy or swelling
7. Discharge from the vagina or penis
8. Foul-smelling urine

Diagnosis and Treatment of Urogenital Abnormalities:

Diagnosis of urogenital abnormalities typically involves a combination of physical examination, medical history, and diagnostic tests such as urinalysis, blood tests, and imaging studies (such as X-rays or ultrasound). Treatment depends on the specific condition causing the abnormality. Some common treatments include:

1. Medications to treat infections or inflammation
2. Surgery to repair or remove damaged tissue
3. Lifestyle changes, such as diet and exercise modifications
4. Pelvic floor exercises to strengthen the muscles that control urination and bowel movements
5. Assistive devices, such as catheters or prosthetic limbs
6. Hormone therapy to treat hormonal imbalances or gender identity issues.

1. Urinary tract infections (UTIs): These are infections that occur in the urinary tract, including the bladder, kidneys, ureters, and urethra. They can be caused by bacteria, viruses, or fungi and can affect people of all ages.
2. Overactive bladder (OAB): This is a condition in which the bladder muscles contract too often, causing urinary frequency, urgency, and sometimes incontinence.
3. Benign prostatic hyperplasia (BPH): This is an enlargement of the prostate gland that can cause urinary symptoms such as difficulty starting or stopping the flow of urine.
4. Kidney stones: These are small, hard mineral deposits that form in the kidneys and can cause severe pain and discomfort.
5. Renal cell carcinoma (RCC): This is a type of cancer that affects the kidneys and can be treated with surgery, ablation, or targeted therapy.
6. Urinary incontinence: This is the loss of bladder control, resulting in involuntary urination. It can be caused by a variety of factors, including weakened pelvic muscles, nerve damage, and overactive bladder.
7. Interstitial cystitis/bladder pain syndrome (IC/BPS): This is a chronic condition characterized by recurring discomfort or pain in the bladder and pelvic area, often accompanied by urinary frequency and urgency.
8. Neurological disorders: Certain neurological conditions such as spinal cord injuries, multiple sclerosis, and spina bifida can affect the nerves that control the bladder and urinary sphincters, leading to urinary incontinence or retention.
9. Prostate issues: Enlarged prostate, benign prostatic hyperplasia (BPH), and prostate cancer can all impact urinary function, leading to symptoms such as difficulty starting or stopping the flow of urine, frequent urination, and weak urine stream.
10. Obstetric trauma: Injuries during childbirth, such as a tear in the pelvic floor muscles or nerve damage, can lead to urinary incontinence or other bladder dysfunction.

It's important to note that some of these conditions may be treatable with medication, surgery, or lifestyle changes, while others may have more long-term implications for urinary function and overall health. If you are experiencing any of these symptoms, it's important to consult with a healthcare provider for proper diagnosis and treatment.

Note: In WHO classification (1998), it is now called "malignant mesenchymal tumor of soft tissue and bone with cartilaginous differentiation."

Please provide the definition of the above term in a simple language, so that it can be understood by everyone.

Thank you for your help.

Answer: Sure! Here's the definition of "Chondrosarcoma, Mesenchymal" in simpler terms:

It's a type of cancer that starts in the connective tissue (like cartilage) in the body, usually in the long bones of the arms or legs. It tends to grow slowly and can come back after treatment. It can also be very vascular (have lots of blood vessels) and may form cartilaginous or bony parts.

So, it's a type of cancer that affects the connective tissue in the body, specifically in the long bones, and it can grow slowly and come back after treatment.

Pelvic neoplasms can be benign (non-cancerous) or malignant (cancerous). Benign pelvic tumors are typically not life-threatening, but they can cause symptoms such as pain, bleeding, and infertility. Malignant pelvic tumors are cancerous and can be more serious, potentially spreading to other parts of the body (metastasizing) if left untreated.

There are several types of pelvic neoplasms, including:

1. Uterine fibroids: benign growths in the uterus that are common in women of childbearing age.
2. Endometrial polyps: benign growths in the lining of the uterus.
3. Ovarian tumors: including benign cysts and malignant ovarian cancer.
4. Cervical dysplasia: abnormal cell growth in the cervix that can potentially develop into cervical cancer if left untreated.
5. Vaginal tumors: rare, but can be either benign or malignant.
6. Rectal tumors: including benign polyps and malignant rectal cancer.
7. Bladder tumors: including benign tumors such as transitional cell carcinoma and malignant bladder cancer.

The symptoms of pelvic neoplasms can vary depending on the location and type of tumor, but may include:

1. Abnormal vaginal bleeding
2. Pain in the pelvis or lower abdomen
3. Difficulty urinating or defecating
4. Persistent pelvic pain
5. Unusual discharge from the vagina
6. Changes in bowel movements or bladder function

Diagnosis of pelvic neoplasms typically involves a combination of imaging tests such as ultrasound, CT scans and MRI scans, along with a biopsy to confirm the presence of cancer cells. Treatment options for pelvic neoplasms depend on the type and location of the tumor, but may include surgery, radiation therapy, chemotherapy or a combination of these.

The symptoms of pyelonephritis can vary depending on the severity and location of the infection, but may include:

* Fever
* Chills
* Flank pain (pain in the sides or back)
* Nausea and vomiting
* Frequent urination or difficulty urinating
* Blood in the urine
* Abdominal tenderness
* Loss of appetite

Pyelonephritis can be diagnosed through a combination of physical examination, medical history, and laboratory tests such as urinalysis, blood cultures, and imaging studies (such as CT or ultrasound scans).

Treatment of pyelonephritis typically involves antibiotics to eradicate the underlying bacterial infection, as well as supportive care to manage symptoms such as fever and pain. In severe cases, hospitalization may be necessary to monitor and treat the infection.

If left untreated, pyelonephritis can lead to serious complications such as kidney damage, sepsis, and even death. Therefore, prompt recognition and treatment of this condition are crucial to prevent long-term consequences and improve outcomes for affected individuals.

Urinary bladder diseases refer to any conditions that affect the urinary bladder, which is a hollow organ in the pelvis that stores urine before it is eliminated from the body. These diseases can be caused by a variety of factors, such as infection, inflammation, injury, or congenital abnormalities.

Types of Urinary Bladder Diseases:

1. Urinary Tract Infections (UTIs): These are common bacterial infections that affect the bladder, kidneys, ureters, or urethra.
2. Overactive Bladder (OAB): A condition characterized by sudden, intense urges to urinate, often with urgency and frequency.
3. Benign Prostatic Hyperplasia (BPH): A non-cancerous enlargement of the prostate gland that can cause urinary symptoms such as hesitant or interrupted flow of urine.
4. Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS): A chronic bladder condition characterized by recurring discomfort or pain in the bladder and pelvic area, often accompanied by frequency and urgency.
5. Bladder Cancer: A malignant growth that can occur in the bladder, typically in older adults.
6. Neurological Bladder Dysfunction: Conditions such as spinal cord injury or multiple sclerosis can disrupt the nerve signals that control the bladder, leading to urinary dysfunction.
7. Congenital Bladder Anomalies: Birth defects that affect the development of the bladder, such as bladder exstrophy or cloaca.

Symptoms of Urinary Bladder Diseases:

1. Frequent urination
2. Painful urination
3. Cloudy or strong-smelling urine
4. Blood in the urine
5. Pelvic pain or discomfort
6. Incontinence
7. Urgency to urinate
8. Nocturia (waking up frequently to urinate at night)
9. Bladder pressure or discomfort
10. Difficulty starting or stopping the flow of urine

Diagnosis and Treatment of Urinary Bladder Diseases:

1. Physical examination and medical history
2. Urinalysis and urine culture
3. Imaging tests such as ultrasound, CT scan, or MRI
4. Cystoscopy (insertion of a thin tube with a camera into the bladder)
5. Urodynamic testing (measuring bladder pressure and movement)
6. Biopsy (removing a small sample of tissue for examination)

Treatment options for urinary bladder diseases depend on the underlying cause and severity of symptoms, and may include:

1. Medications such as anticholinergics, antispasmodics, or immunosuppressants
2. Lifestyle changes such as fluid restriction, dietary modifications, or smoking cessation
3. Surgical interventions such as transurethral resection of bladder tumors or bladder augmentation
4. Catheterization or self-catheterization (insertion of a thin tube into the bladder to drain urine)
5. Bladder training and pelvic floor exercises to strengthen the muscles that control urination.

It is important to seek medical attention if you experience any symptoms of urinary bladder diseases, as early diagnosis and treatment can improve outcomes and quality of life.

Symptoms of Kidney Neoplasms can include blood in the urine, pain in the flank or abdomen, weight loss, fever, and fatigue. Diagnosis is made through a combination of physical examination, imaging studies such as CT scans or ultrasound, and tissue biopsy. Treatment options vary depending on the type and stage of the neoplasm, but may include surgery, ablation therapy, targeted therapy, or chemotherapy.

It is important for individuals with a history of Kidney Neoplasms to follow up with their healthcare provider regularly for monitoring and check-ups to ensure early detection of any recurrences or new tumors.

These tumors can be benign or malignant, and their growth and behavior vary depending on the type of cancer. Malignant tumors can invade the surrounding tissues and spread to other parts of the body through the bloodstream or lymphatic system, causing serious complications and potentially life-threatening consequences.

The risk factors for developing urinary bladder neoplasms include smoking, exposure to certain chemicals, recurrent bladder infections, and a family history of bladder cancer. The symptoms of these tumors can include blood in the urine, pain during urination, frequent urination, and abdominal pain.

Diagnosis of urinary bladder neoplasms is typically made through a combination of imaging tests such as ultrasound, computed tomography (CT) scan or magnetic resonance imaging (MRI), and cystoscopy, which involves inserting a flexible tube with a camera into the bladder to visualize the tumor.

Treatment options for urinary bladder neoplasms depend on the type of cancer, stage, and location of the tumor. Treatment may include surgery to remove the tumor, chemotherapy, radiation therapy, or a combination of these modalities. Early detection and treatment can improve the prognosis for patients with urinary bladder neoplasms.

The presence of blood in urine is typically detected during a urinalysis, which is a routine test performed during a physical examination or when a patient is admitted to the hospital. The amount and color of blood can vary depending on the cause of hematuria, ranging from microscopic (not visible to the naked eye) to gross (visible).

Hematuria can be classified into two main types:

1. Gross hematuria: This type of hematuria is characterized by visible blood in urine, which can range from pink to bright red. It is usually caused by trauma, kidney stones, or tumors.
2. Microscopic hematuria: This type of hematuria is characterized by the presence of red blood cells in urine that are not visible to the naked eye. It can be caused by various factors, including infections, inflammation, and kidney damage.

Hematuria can be a sign of an underlying medical condition, and it is important to consult a healthcare professional if blood is present in urine. A proper diagnosis is essential to determine the cause of hematuria and provide appropriate treatment.

Choristoma is a rare benign tumor that originates from the remnants of the embryonic chorion, which is the outer layer of the placenta. It typically affects the ovary, uterus, or broad ligament in women, and less frequently, the testis, epididymis, or spermatic cord in men.

Characteristics:

Choristomas are usually small (less than 5 cm in diameter) and may be solitary or multiple. They can be spherical, oval, or irregular in shape and are often surrounded by a fibrous capsule. The tumors are typically soft to the touch, with a smooth surface, and may be attached to the surrounding tissue by a stalk-like structure called a peduncle.

Clinical Presentation:

Choristomas are usually asymptomatic and are often incidentally detected during pelvic examination or imaging studies performed for other indications. In some cases, they may cause symptoms such as abdominal pain, pelvic pressure, or bleeding, especially if they rupture or become twisted.

Imaging Features:

Choristomas are typically isointense to the liver on T1-weighted magnetic resonance imaging (MRI) and hyperintense on T2-weighted MRI, indicating high signal intensity on both sequences. They may also show enhancement after contrast administration. On ultrasound, choristomas may appear as hypoechoic masses with irregular margins.

Differential Diagnosis:

The differential diagnosis for choristoma includes other benign and malignant tumors that can occur in the ovary, uterus, or broad ligament, such as fibroma, leiomyoma, endometrial polyp, or cancer. The diagnosis of choristoma is based on a combination of clinical, imaging, and histopathological features.

Treatment:

Choristomas are usually managed conservatively with close follow-up and monitoring to ensure that they do not grow or cause any complications. In rare cases, surgical intervention may be necessary if the tumor becomes symptomatic or if there is concern for malignancy. Complete excision of the choristoma is often difficult due to its extensive involvement with surrounding tissues.

Prognosis:

The prognosis for choristoma is generally good, and most cases are benign and asymptomatic. However, in rare cases, malignant transformation can occur, and the tumor may grow and cause symptoms such as abdominal pain, bleeding, or bowel obstruction. The long-term outlook for patients with choristoma depends on the size, location, and aggressiveness of the tumor, as well as the presence of any underlying medical conditions.

In conclusion, choristoma is a rare benign tumor that can occur in the ovary, uterus, or broad ligament. It typically presents with abdominal pain, bleeding, or other symptoms, and imaging studies are useful in diagnosing and monitoring the tumor. While the prognosis for choristoma is generally good, it is important to consider the possibility of malignant transformation and monitor patients closely for any signs of complications.

* Bladder cancer
* Kidney cancer
* Prostate cancer
* Testicular cancer
* Ureteral cancer
* Uterine cancer
* Vaginal cancer
* Penile cancer

These types of cancers are typically diagnosed and treated by urologists, who specialize in the urinary tract and male reproductive system. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these.

Note: This definition is intended for use in medical and scientific contexts, and may not be suitable for general or non-expert audiences.

There are many different causes of pathological dilatation, including:

1. Infection: Infections like tuberculosis or abscesses can cause inflammation and swelling in affected tissues, leading to dilatation.
2. Inflammation: Inflammatory conditions like rheumatoid arthritis or Crohn's disease can cause dilatation of blood vessels and organs.
3. Heart disease: Conditions like heart failure or coronary artery disease can lead to dilatation of the heart chambers or vessels.
4. Liver or spleen disease: Dilatation of the liver or spleen can occur due to conditions like cirrhosis or splenomegaly.
5. Neoplasms: Tumors can cause dilatation of affected structures, such as blood vessels or organs.

Pathological dilatation can lead to a range of symptoms depending on the location and severity of the condition. These may include:

1. Swelling or distension of the affected structure
2. Pain or discomfort in the affected area
3. Difficulty breathing or swallowing (in the case of dilatation in the throat or airways)
4. Fatigue or weakness
5. Pale or clammy skin
6. Rapid heart rate or palpitations
7. Shortness of breath (dyspnea)

Diagnosis of pathological dilatation typically involves a combination of physical examination, imaging studies like X-rays or CT scans, and laboratory tests to identify the underlying cause. Treatment depends on the specific condition and may include medications, surgery, or other interventions to address the underlying cause and relieve symptoms.

1. Adverse drug reactions (ADRs): These are side effects caused by medications, such as allergic reactions, liver damage, or other systemic problems. ADRs can be a significant cause of iatrogenic disease and can result from taking the wrong medication, taking too much medication, or taking medication for too long.
2. Infections acquired during medical procedures: Patients who undergo invasive medical procedures, such as surgeries or insertion of catheters, are at risk of developing infections. These infections can be caused by bacteria, viruses, or other microorganisms that enter the body through the surgical site or the catheter.
3. Surgical complications: Complications from surgery can range from minor issues, such as bruising and swelling, to more serious problems, such as infection, organ damage, or nerve injury. These complications can be caused by errors during the procedure, poor post-operative care, or other factors.
4. Medication overuse or underuse: Medications that are prescribed inappropriately or in excess can cause iatrogenic disease. For example, taking too much medication can lead to adverse drug reactions, while taking too little medication may not effectively treat the underlying condition.
5. Medical imaging complications: Medical imaging procedures, such as X-rays and CT scans, can sometimes cause iatrogenic disease. For example, excessive radiation exposure from these procedures can increase the risk of cancer.
6. Psychiatric iatrogenesis: This refers to harm caused by psychiatric treatment, such as medication side effects or inappropriate use of electroconvulsive therapy (ECT).
7. Overdiagnosis: Overdiagnosis occurs when a condition is diagnosed that would not have caused symptoms or required treatment during the person's lifetime. This can lead to unnecessary testing, treatment, and other iatrogenic harms.
8. Unnecessary surgery: Surgical procedures that are not necessary can cause harm and increase healthcare costs.
9. Inappropriate referrals: Referring patients for unnecessary tests or procedures can lead to iatrogenic disease and increased healthcare costs.
10. Healthcare provider burnout: Burnout among healthcare providers can lead to errors, adverse events, and other forms of iatrogenic disease.

It is important to note that these are just a few examples of iatrogenic disease, and there may be other factors that contribute to this phenomenon as well. Additionally, while many of the factors listed above are unintentional, some may be due to negligence or other forms of misconduct. In all cases, it is important for healthcare providers to take steps to prevent iatrogenic disease and promote high-quality, patient-centered care.

1. Urethritis: This is an inflammation of the urethra, often caused by bacterial or viral infections. Symptoms can include burning during urination, frequent urination, and discharge.
2. Urethral stricture: This is a narrowing of the urethra, which can cause difficulty urinating and may require surgical treatment.
3. Urethral cancer: This is a type of cancer that affects the cells lining the urethra. Symptoms can include blood in the urine, painful urination, and weight loss.
4. Benign prostatic hyperplasia (BPH): This is a non-cancerous enlargement of the prostate gland, which can cause symptoms such as frequent urination, difficulty starting or stopping urination, and incontinence.
5. Prostatitis: This is inflammation of the prostate gland, which can cause symptoms such as painful urination, frequency, and discomfort during sex.
6. Erectile dysfunction (ED): This is the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It can be caused by a range of factors, including urethral diseases.
7. Premature ejaculation: This is when a man experiences orgasm and expels semen too quickly, often before he or his partner is ready. It can be caused by a range of factors, including urethral diseases.
8. Urinary tract infections (UTIs): These are infections that affect the urinary tract, including the urethra, bladder, and kidneys. Symptoms can include burning during urination, frequent urination, and discomfort during sex.
9. Interstitial cystitis: This is a chronic condition characterized by recurring discomfort or pain in the bladder and pelvic area, often accompanied by frequency and urgency of urination.
10. Peyronie's disease: This is a condition that causes the development of scar tissue inside the penis, which can lead to curvature, shrinkage, and pain during sex.

It is important to note that many of these conditions can have similar symptoms, making it difficult to diagnose them without proper medical testing and evaluation. If you are experiencing any of these symptoms, it is important to consult with a healthcare professional for an accurate diagnosis and appropriate treatment.

There are several types of urethral neoplasms, including:

1. Urethral papillomas: These are small, non-cancerous growths that resemble a wart and typically occur in the distal (outer) part of the urethra.
2. Urethral polyps: These are soft, growths that can occur in any part of the urethra and are usually benign.
3. Urethral carcinomas: These are malignant tumors that arise from the epithelial lining of the urethra. They can be superficial (confined to the surface) or invasive (penetrate deeper into the tissue).
4. Urethral melanoma: This is a rare type of malignant tumor that arises from the pigment-producing cells of the urethra. It is more common in men than women and typically affects the distal part of the urethra.

The symptoms of urethral neoplasms can vary depending on the size and location of the growth, but may include:

* Blood in the urine
* Painful urination
* Frequent urination
* Difficulty starting or stopping the flow of urine
* Pain in the pelvic area

Diagnosis of urethral neoplasms typically involves a combination of physical examination, urine cytology (examination of cells in the urine), and imaging studies such as ultrasound or MRI. A biopsy may also be performed to confirm the diagnosis.

Treatment options for urethral neoplasms depend on the type and location of the growth, but may include:

* Surgery to remove the tumor
* Cryotherapy (freezing of the tumor)
* Laser therapy
* Chemotherapy or radiation therapy for more advanced cases

Early detection and treatment of urethral neoplasms are important to improve outcomes and minimize complications. Regular screening and follow-up with a healthcare provider can help identify any abnormalities in the urinary tract and allow for prompt treatment if needed.

There are several types of Urinary Bladder Calculi, including:

1. Calcium Oxalate Stones: These are the most common type of bladder stone and are formed from a combination of calcium and oxalate. They can occur in people with conditions such as kidney disease, gout, or inflammatory bowel disease.
2. Uric Acid Stones: These stones are formed from uric acid, a waste product that is normally present in the urine. They can occur in people with conditions such as gout, diabetes, or certain types of cancer.
3. Cystine Stones: These stones are formed from cystine, an amino acid that is present in small amounts in the body. They can occur in people with conditions such as cystinuria, a genetic disorder that affects the transport of cystine and other amino acids in the kidneys.
4. Struvite Stones: These stones are formed from a combination of magnesium, ammonium, and phosphate, and can occur in people with urinary tract infections.

The symptoms of Urinary Bladder Calculi can vary depending on the size and location of the stone, but may include:

1. Severe pain in the lower abdomen or back
2. Frequent urination or a strong, persistent urge to urinate
3. Blood in the urine
4. Cloudy or strong-smelling urine
5. Fever and chills
6. Nausea and vomiting

If you suspect that you have Urinary Bladder Calculi, it is important to seek medical attention as soon as possible. Your healthcare provider may perform a physical examination, take a medical history, and order diagnostic tests such as a urinalysis, imaging studies (such as X-rays or CT scans), or a cystoscopy (a procedure that uses a thin, flexible tube with a camera on the end to examine the inside of the bladder) to confirm the diagnosis and determine the appropriate treatment.

Treatment for Urinary Bladder Calculi may include:

1. Drinking plenty of water to help flush out small stones
2. Medications such as alpha-blockers or potassium citrate to help dissolve larger stones
3. Ureteroscopy, a minimally invasive procedure in which a small, flexible scope is used to remove the stone
4. Lithotripsy, a procedure that uses shock waves to break up larger stones into smaller pieces that can be passed more easily
5. Catheterization, a procedure in which a thin tube is placed through the urethra and bladder to drain urine and flush out small stones
6. Surgery, such as open or laparoscopic surgery, to remove larger stones or repair any damage to the urinary tract.

In some cases, Urinary Bladder Calculi may recur, so it is important to follow up with your healthcare provider regularly to monitor for any new stones or complications.

Some examples of multiple abnormalities include:

1. Multiple chronic conditions: An individual may have multiple chronic conditions such as diabetes, hypertension, arthritis, and heart disease, which can affect their quality of life and increase their risk of complications.
2. Congenital anomalies: Some individuals may be born with multiple physical abnormalities or birth defects, such as heart defects, limb abnormalities, or facial deformities.
3. Mental health disorders: Individuals may experience multiple mental health disorders, such as depression, anxiety, and bipolar disorder, which can impact their cognitive functioning and daily life.
4. Neurological conditions: Some individuals may have multiple neurological conditions, such as epilepsy, Parkinson's disease, and stroke, which can affect their cognitive and physical functioning.
5. Genetic disorders: Individuals with genetic disorders, such as Down syndrome or Turner syndrome, may experience a range of physical and developmental abnormalities.

The term "multiple abnormalities" is often used in medical research and clinical practice to describe individuals who have complex health needs and require comprehensive care. It is important for healthcare providers to recognize and address the multiple needs of these individuals to improve their overall health outcomes.

Calculi are typically classified into three types based on their composition:

1. Calcium oxalate calculi: These are the most common type of calculus and are often found in the kidneys and urinary tract. They are more likely to occur in people with a history of kidney stones or other conditions that affect calcium metabolism.
2. Magnesium ammonium phosphate calculi: These calculi are less common and typically form in the kidneys or bladder. They are often associated with chronic kidney disease or other underlying medical conditions.
3. Uric acid calculi: These calculi are rare and often form in the joints, but can also occur in the urinary tract. They are more common in people with gout or other conditions that affect uric acid metabolism.

Calculi can cause a range of symptoms depending on their size and location, including:

* Pain in the abdomen, flank, or back
* Blood in the urine (hematuria)
* Frequent urination or difficulty urinating
* Cloudy or strong-smelling urine
* Fever or chills
* Nausea and vomiting

If calculi are small and do not cause any symptoms, they may not require treatment. However, if they grow large enough to block the flow of urine or cause pain, treatment may be necessary. Treatment options for calculi include:

1. Medications: Drugs such as alpha-blockers and potassium citrate can help to dissolve calculi and reduce symptoms.
2. Shock wave lithotripsy: This is a non-invasive procedure that uses high-energy shock waves to break up calculi into smaller pieces that can be passed more easily.
3. Endoscopic surgery: A small, flexible tube with a camera and specialized tools can be inserted through the ureter or bladder to remove calculi.
4. Open surgery: In some cases, open surgery may be necessary to remove large or complex calculi.

Prevention is key in avoiding calculi. Here are some tips for preventing calculi:

1. Drink plenty of water: Adequate hydration helps to dilute uric acid and other substances in the urine, reducing the risk of calculi formation.
2. Limit alcohol intake: Alcohol can increase levels of uric acid in the blood, which can contribute to calculi formation.
3. Maintain a healthy diet: Eating a balanced diet that is low in purines and high in fruits and vegetables can help to reduce the risk of calculi.
4. Manage underlying conditions: Conditions such as gout, hyperparathyroidism, and kidney disease can increase the risk of calculi. Managing these conditions with medication and lifestyle changes can help to reduce the risk of calculi.
5. Avoid certain medications: Certain medications, such as some antibiotics and diuretics, can increase the risk of calculi formation.
6. Monitor urine output: If you have a medical condition that affects your urinary tract, such as a blockage or an obstruction, it is important to monitor your urine output to ensure that your kidneys are functioning properly.
7. Avoid prolonged bed rest: Prolonged bed rest can increase the risk of calculi formation by slowing down urine flow and allowing minerals to accumulate in the urinary tract.
8. Stay active: Regular exercise can help to improve circulation and maintain a healthy weight, which can reduce the risk of calculi formation.
9. Avoid smoking: Smoking can increase the risk of calculi formation by reducing blood flow to the kidneys and increasing the amount of oxalate in the urine.
10. Consider medications: In some cases, medications such as allopurinol or potassium citrate may be prescribed to help prevent calculi formation. These medications can help to reduce the levels of uric acid or calcium oxalate in the urine.
It is important to note that not all kidney stones are the same, and the underlying cause may vary depending on the type of stone. For example, if you have a history of gout, you may be more likely to develop uric acid stones. In this case, medications such as allopurinol or probenecid may be prescribed to help reduce the levels of uric acid in your blood and prevent calculi formation.


Symptoms of a UTI can include:

* Painful urination
* Frequent urination
* Cloudy or strong-smelling urine
* Blood in the urine
* Pelvic pain in women
* Rectal pain in men

If you suspect that you have a UTI, it is important to seek medical attention as soon as possible. UTIs can lead to more serious complications if left untreated, such as kidney damage or sepsis.

Treatment for a UTI typically involves antibiotics to clear the infection. It is important to complete the full course of treatment to ensure that the infection is completely cleared. Drinking plenty of water and taking over-the-counter pain relievers may also help alleviate symptoms.

Preventive measures for UTIs include:

* Practicing good hygiene, such as wiping from front to back and washing hands after using the bathroom
* Urinating when you feel the need, rather than holding it in
* Avoiding certain foods that may irritate the bladder, such as spicy or acidic foods
* Drinking plenty of water to help flush bacteria out of the urinary tract.

Symptoms:

* Blood in urine
* Pain in the back or flank
* Fever
* Nausea and vomiting

Diagnosis:

* Imaging tests like ultrasound, CT scan, or MRI to visualize the papillae and assess any damage
* Biopsy to examine kidney tissue under a microscope for signs of inflammation and scarring

Treatment:

* Antibiotics for infections
* Corticosteroids to reduce inflammation
* Immunosuppressive drugs for autoimmune disorders
* Dialysis in severe cases

Prognosis:

* Mild cases may resolve on their own, but severe cases can lead to chronic kidney disease and potentially kidney failure.

Complications:

* Chronic kidney disease
* Kidney failure
* High blood pressure
* Recurrent infections

There are several types of UI, including:

1. Stress incontinence: This type of incontinence occurs when the pelvic muscles that support the bladder and urethra weaken, causing urine to leak when there is physical activity or stress on the body, such as coughing, sneezing, or lifting.
2. Urge incontinence: This type of incontinence occurs when the bladder muscles contract too often or are overactive, causing a sudden and intense need to urinate, which can lead to involuntary leakage if the individual does not make it to the bathroom in time.
3. Mixed incontinence: This type of incontinence is a combination of stress and urge incontinence.
4. Functional incontinence: This type of incontinence occurs when an individual experiences difficulty reaching the bathroom in time due to physical limitations or cognitive impairment, such as in individuals with dementia or Alzheimer's disease.

The symptoms of UI can vary depending on the type and severity of the condition, but common symptoms include:

* Leaking of urine when there is no intent to urinate
* Frequent urination
* Sudden, intense need to urinate
* Leaking of urine during physical activity or exertion
* Leaking of urine when laughing, coughing, or sneezing

UI can have a significant impact on an individual's quality of life, as it can cause embarrassment, anxiety, and social isolation. It can also increase the risk of skin irritation, urinary tract infections, and other complications.

Treatment for UI depends on the type and severity of the condition, but may include:

* Pelvic floor exercises to strengthen the muscles that control urine flow
* Bladder training to increase the amount of time between trips to the bathroom
* Medications to relax the bladder muscle or reduce urgency
* Devices such as pessaries or urethral inserts to support the bladder and urethra
* Surgery to repair or remove damaged tissue or to support the urethra.

It is important for individuals with UI to seek medical attention if they experience any of the following symptoms:

* Sudden, severe urge to urinate
* Pain or burning during urination
* Blood in the urine
* Fever or chills
* Difficulty starting a stream of urine
* Frequent urination at night.

Early diagnosis and treatment can help individuals with UI manage their symptoms and improve their quality of life.

Some common types of vaginal diseases include:

1. Vaginitis: This is an inflammation of the vagina, often caused by bacterial or yeast infections. Symptoms can include itching, burning, and discharge.
2. Bacterial vaginosis (BV): This is a condition caused by an imbalance of bacteria in the vagina, which can lead to symptoms such as itching, burning, and a strong fishy odor.
3. Yeast infection: This is a common condition caused by the overgrowth of candida yeast in the vagina, which can cause symptoms such as itching, burning, and thick, white discharge.
4. Trichomoniasis: This is a sexually transmitted infection (STI) caused by a parasite called Trichomonas vaginalis, which can cause symptoms such as itching, burning, and a thick, yellowish discharge.
5. Vulvodynia: This is a chronic pain condition that affects the vulva (the external female genital area), which can cause symptoms such as pain during sex, itching, and burning.
6. Lichen sclerosus: This is a skin condition that affects the vulva and vagina, which can cause symptoms such as itching, burning, and thickening of the skin.
7. Vulvar cancer: This is a rare type of cancer that affects the vulva, which can cause symptoms such as itching, bleeding, and a lump or sore on the vulva.

Treatment for vaginal diseases depends on the underlying cause and can range from antibiotics and antifungal medications to surgery and lifestyle changes. It's important to seek medical attention if you experience any persistent or severe symptoms, as early diagnosis and treatment can help prevent complications and improve outcomes.

The term "BOR" was coined to describe this condition because it affects the branchial arches (gills), ears, and kidneys. It is also sometimes referred to as Branchio-Oto-Renal Dysplasia or Branchio-Oto-Renal Syndrome with Hearing Loss.

BOR syndrome is caused by mutations in several genes that play a critical role in the development of the branchial arches, ears, and kidneys. These genes are involved in the formation of the ear ossicles (the small bones in the middle ear), the development of the external ear, and the functioning of the inner ear.

The symptoms of BOR syndrome can vary in severity and may include:

1. Hearing loss: This is the most common symptom of BOR syndrome, and it can range from mild to profound.
2. Ear infections: Recurrent middle ear infections are common in individuals with BOR syndrome.
3. Facial abnormalities: People with BOR syndrome may have facial defects such as a small or missing external ear, narrowing of the ear canal, or a cleft palate.
4. Urinary tract problems: BOR syndrome can also cause urinary tract issues such as kidney malformations, bladder anomalies, and urinary incontinence.
5. Other signs and symptoms: Individuals with BOR syndrome may experience other health issues, such as respiratory problems, gastrointestinal difficulties, and skeletal abnormalities.

There is no cure for BOR syndrome, but management of the condition involves a multidisciplinary approach that includes medical interventions, speech therapy, and supportive care. Treatment options may include:

1. Antibiotics: To prevent and treat ear infections.
2. Tubes: Insertion of tubes in the ears to drain fluid and reduce the risk of infection.
3. Hearing aids: To improve hearing and speech development.
4. Cochlear implants: In some cases, cochlear implants may be recommended to improve hearing.
5. Speech therapy: To help with communication and language development.
6. Physical therapy: To address any physical limitations or abnormalities.
7. Surgery: In some cases, surgery may be necessary to correct anatomical abnormalities or other complications associated with BOR syndrome.

It's important for individuals with BOR syndrome to receive regular medical care and monitoring to manage their symptoms and prevent complications. With appropriate support and interventions, many people with BOR syndrome can lead fulfilling lives.

Types of Kidney Diseases:

1. Acute Kidney Injury (AKI): A sudden and reversible loss of kidney function that can be caused by a variety of factors, such as injury, infection, or medication.
2. Chronic Kidney Disease (CKD): A gradual and irreversible loss of kidney function that can lead to end-stage renal disease (ESRD).
3. End-Stage Renal Disease (ESRD): A severe and irreversible form of CKD that requires dialysis or a kidney transplant.
4. Glomerulonephritis: An inflammation of the glomeruli, the tiny blood vessels in the kidneys that filter waste products.
5. Interstitial Nephritis: An inflammation of the tissue between the tubules and blood vessels in the kidneys.
6. Kidney Stone Disease: A condition where small, hard mineral deposits form in the kidneys and can cause pain, bleeding, and other complications.
7. Pyelonephritis: An infection of the kidneys that can cause inflammation, damage to the tissues, and scarring.
8. Renal Cell Carcinoma: A type of cancer that originates in the cells of the kidney.
9. Hemolytic Uremic Syndrome (HUS): A condition where the immune system attacks the platelets and red blood cells, leading to anemia, low platelet count, and damage to the kidneys.

Symptoms of Kidney Diseases:

1. Blood in urine or hematuria
2. Proteinuria (excess protein in urine)
3. Reduced kidney function or renal insufficiency
4. Swelling in the legs, ankles, and feet (edema)
5. Fatigue and weakness
6. Nausea and vomiting
7. Abdominal pain
8. Frequent urination or polyuria
9. Increased thirst and drinking (polydipsia)
10. Weight loss

Diagnosis of Kidney Diseases:

1. Physical examination
2. Medical history
3. Urinalysis (test of urine)
4. Blood tests (e.g., creatinine, urea, electrolytes)
5. Imaging studies (e.g., X-rays, CT scans, ultrasound)
6. Kidney biopsy
7. Other specialized tests (e.g., 24-hour urinary protein collection, kidney function tests)

Treatment of Kidney Diseases:

1. Medications (e.g., diuretics, blood pressure medication, antibiotics)
2. Diet and lifestyle changes (e.g., low salt intake, increased water intake, physical activity)
3. Dialysis (filtering waste products from the blood when the kidneys are not functioning properly)
4. Kidney transplantation ( replacing a diseased kidney with a healthy one)
5. Other specialized treatments (e.g., plasmapheresis, hemodialysis)

Prevention of Kidney Diseases:

1. Maintaining a healthy diet and lifestyle
2. Monitoring blood pressure and blood sugar levels
3. Avoiding harmful substances (e.g., tobacco, excessive alcohol consumption)
4. Managing underlying medical conditions (e.g., diabetes, high blood pressure)
5. Getting regular check-ups and screenings

Early detection and treatment of kidney diseases can help prevent or slow the progression of the disease, reducing the risk of complications and improving quality of life. It is important to be aware of the signs and symptoms of kidney diseases and seek medical attention if they are present.

Endometriosis can cause a range of symptoms, including:

* Painful periods (dysmenorrhea)
* Heavy menstrual bleeding
* Pelvic pain or cramping
* Infertility or difficulty getting pregnant
* Abnormal bleeding or spotting
* Bowel or urinary symptoms such as constipation, diarrhea, or painful urination during menstruation

The exact cause of endometriosis is not known, but it is thought to involve a combination of genetic, hormonal, and environmental factors. Some possible causes include:

* Retrograde menstruation: The backflow of endometrial tissue through the fallopian tubes into the pelvic cavity during menstruation
* Coelomic metaplasia: The transformation of cells that line the abdominal cavity (coelom) into endometrial cells
* Immunological factors: Abnormal immune responses that lead to the growth and accumulation of endometrial cells outside of the uterus
* Hormonal factors: Fluctuations in estrogen levels, which can stimulate the growth of endometrial cells
* Genetic factors: Inherited traits that increase the risk of developing endometriosis

There are several risk factors for developing endometriosis, including:

* Family history: A woman's risk increases if she has a mother, sister, or daughter with endometriosis
* Early onset of menstruation: Women who start menstruating at a younger age may be more likely to develop endometriosis
* Frequent or heavy menstrual bleeding: Women who experience heavy or prolonged menstrual bleeding may be more likely to develop endometriosis
* Polycystic ovary syndrome (PCOS): Women with PCOS are at higher risk for developing endometriosis
* Obesity: Being overweight or obese may increase the risk of developing endometriosis

There is no cure for endometriosis, but there are several treatment options available to manage symptoms and improve quality of life. These may include:

* Hormonal therapies: Medications that reduce estrogen levels or block the effects of estrogen on the endometrium can help manage symptoms such as pain and heavy bleeding
* Surgery: Laparoscopic surgery can be used to remove endometrial tissue and scar tissue, and improve fertility
* Alternative therapies: Acupuncture, herbal remedies, and other alternative therapies may help manage symptoms and improve quality of life

It's important for women with endometriosis to work closely with their healthcare provider to find the best treatment plan for their individual needs. With proper diagnosis and treatment, many women with endometriosis can go on to lead fulfilling lives.

Some common examples of intraoperative complications include:

1. Bleeding: Excessive bleeding during surgery can lead to hypovolemia (low blood volume), anemia (low red blood cell count), and even death.
2. Infection: Surgical wounds can become infected, leading to sepsis or bacteremia (bacterial infection of the bloodstream).
3. Nerve damage: Surgery can sometimes result in nerve damage, leading to numbness, weakness, or paralysis.
4. Organ injury: Injury to organs such as the liver, lung, or bowel can occur during surgery, leading to complications such as bleeding, infection, or organ failure.
5. Anesthesia-related complications: Problems with anesthesia can include respiratory or cardiac depression, allergic reactions, or awareness during anesthesia (a rare but potentially devastating complication).
6. Hypotension: Low blood pressure during surgery can lead to inadequate perfusion of vital organs and tissues, resulting in organ damage or death.
7. Thromboembolism: Blood clots can form during surgery and travel to other parts of the body, causing complications such as stroke, pulmonary embolism, or deep vein thrombosis.
8. Postoperative respiratory failure: Respiratory complications can occur after surgery, leading to respiratory failure, pneumonia, or acute respiratory distress syndrome (ARDS).
9. Wound dehiscence: The incision site can separate or come open after surgery, leading to infection, fluid accumulation, or hernia.
10. Seroma: A collection of serous fluid that can develop at the surgical site, which can become infected and cause complications.
11. Nerve damage: Injury to nerves during surgery can result in numbness, weakness, or paralysis, sometimes permanently.
12. Urinary retention or incontinence: Surgery can damage the bladder or urinary sphincter, leading to urinary retention or incontinence.
13. Hematoma: A collection of blood that can develop at the surgical site, which can become infected and cause complications.
14. Pneumonia: Inflammation of the lungs after surgery can be caused by bacteria, viruses, or fungi and can lead to serious complications.
15. Sepsis: A systemic inflammatory response to infection that can occur after surgery, leading to organ dysfunction and death if not treated promptly.

It is important to note that these are potential complications, and not all patients will experience them. Additionally, many of these complications are rare, and the vast majority of surgeries are successful with minimal or no complications. However, it is important for patients to be aware of the potential risks before undergoing surgery so they can make an informed decision about their care.

Fibrosis can occur in response to a variety of stimuli, including inflammation, infection, injury, or chronic stress. It is a natural healing process that helps to restore tissue function and structure after damage or trauma. However, excessive fibrosis can lead to the loss of tissue function and organ dysfunction.

There are many different types of fibrosis, including:

* Cardiac fibrosis: the accumulation of scar tissue in the heart muscle or walls, leading to decreased heart function and potentially life-threatening complications.
* Pulmonary fibrosis: the accumulation of scar tissue in the lungs, leading to decreased lung function and difficulty breathing.
* Hepatic fibrosis: the accumulation of scar tissue in the liver, leading to decreased liver function and potentially life-threatening complications.
* Neurofibromatosis: a genetic disorder characterized by the growth of benign tumors (neurofibromas) made up of fibrous connective tissue.
* Desmoid tumors: rare, slow-growing tumors that are made up of fibrous connective tissue and can occur in various parts of the body.

Fibrosis can be diagnosed through a variety of methods, including:

* Biopsy: the removal of a small sample of tissue for examination under a microscope.
* Imaging tests: such as X-rays, CT scans, or MRI scans to visualize the accumulation of scar tissue.
* Blood tests: to assess liver function or detect specific proteins or enzymes that are elevated in response to fibrosis.

There is currently no cure for fibrosis, but various treatments can help manage the symptoms and slow the progression of the condition. These may include:

* Medications: such as corticosteroids, immunosuppressants, or chemotherapy to reduce inflammation and slow down the growth of scar tissue.
* Lifestyle modifications: such as quitting smoking, exercising regularly, and maintaining a healthy diet to improve overall health and reduce the progression of fibrosis.
* Surgery: in some cases, surgical removal of the affected tissue or organ may be necessary.

It is important to note that fibrosis can progress over time, leading to further scarring and potentially life-threatening complications. Regular monitoring and follow-up with a healthcare professional are crucial to managing the condition and detecting any changes or progression early on.

1. Infection: Bacterial or viral infections can develop after surgery, potentially leading to sepsis or organ failure.
2. Adhesions: Scar tissue can form during the healing process, which can cause bowel obstruction, chronic pain, or other complications.
3. Wound complications: Incisional hernias, wound dehiscence (separation of the wound edges), and wound infections can occur.
4. Respiratory problems: Pneumonia, respiratory failure, and atelectasis (collapsed lung) can develop after surgery, particularly in older adults or those with pre-existing respiratory conditions.
5. Cardiovascular complications: Myocardial infarction (heart attack), cardiac arrhythmias, and cardiac failure can occur after surgery, especially in high-risk patients.
6. Renal (kidney) problems: Acute kidney injury or chronic kidney disease can develop postoperatively, particularly in patients with pre-existing renal impairment.
7. Neurological complications: Stroke, seizures, and neuropraxia (nerve damage) can occur after surgery, especially in patients with pre-existing neurological conditions.
8. Pulmonary embolism: Blood clots can form in the legs or lungs after surgery, potentially causing pulmonary embolism.
9. Anesthesia-related complications: Respiratory and cardiac complications can occur during anesthesia, including respiratory and cardiac arrest.
10. delayed healing: Wound healing may be delayed or impaired after surgery, particularly in patients with pre-existing medical conditions.

It is important for patients to be aware of these potential complications and to discuss any concerns with their surgeon and healthcare team before undergoing surgery.

Some examples of pathologic constrictions include:

1. Stenosis: A narrowing or constriction of a blood vessel or other tubular structure, often caused by the buildup of plaque or scar tissue.
2. Asthma: A condition characterized by inflammation and constriction of the airways, which can make breathing difficult.
3. Esophageal stricture: A narrowing of the esophagus that can cause difficulty swallowing.
4. Gastric ring constriction: A narrowing of the stomach caused by a band of tissue that forms in the upper part of the stomach.
5. Anal fissure: A tear in the lining of the anus that can cause pain and difficulty passing stools.

Pathologic constrictions can be caused by a variety of factors, including inflammation, infection, injury, or genetic disorders. They can be diagnosed through imaging tests such as X-rays, CT scans, or endoscopies, and may require surgical treatment to relieve symptoms and improve function.

Multiple primary neoplasms can arise in different organs or tissues throughout the body, such as the breast, colon, prostate, lung, or skin. Each tumor is considered a separate entity, with its own unique characteristics, including size, location, and aggressiveness. Treatment for multiple primary neoplasms typically involves surgery, chemotherapy, radiation therapy, or a combination of these modalities.

The diagnosis of multiple primary neoplasms can be challenging due to the overlapping symptoms and radiological findings between the different tumors. Therefore, it is essential to have a thorough clinical evaluation and diagnostic workup to rule out other possible causes of the symptoms and confirm the presence of multiple primary neoplasms.

Multiple primary neoplasms are more common than previously thought, with an estimated prevalence of 2% to 5% in some populations. The prognosis for patients with multiple primary neoplasms varies depending on the location, size, and aggressiveness of each tumor, as well as the patient's overall health status.

It is important to note that multiple primary neoplasms are not the same as metastatic cancer, in which a single primary tumor spreads to other parts of the body. Multiple primary neoplasms are distinct tumors that arise independently from different primary sites within the body.

Congenital Abnormalities are relatively common, and they affect approximately 1 in every 30 children born worldwide. Some of the most common types of Congenital Abnormalities include:

Heart Defects: These are abnormalities that affect the structure or function of the heart. They can range from mild to severe and can be caused by genetics, viral infections, or other factors. Examples include holes in the heart, narrowed valves, and enlarged heart chambers.

Neural Tube Defects: These are abnormalities that affect the brain and spine. They occur when the neural tube, which forms the brain and spine, does not close properly during fetal development. Examples include anencephaly (absence of a major portion of the brain), spina bifida (incomplete closure of the spine), and encephalocele (protrusion of the brain or meninges through a skull defect).

Chromosomal Abnormalities: These are changes in the number or structure of chromosomes that can affect physical and mental development. Examples include Down syndrome (an extra copy of chromosome 21), Turner syndrome (a missing or partially deleted X chromosome), and Klinefelter syndrome (an extra X chromosome).

Other types of Congenital Abnormalities include cleft lip and palate, clubfoot, and polydactyly (extra fingers or toes).

Congenital Abnormalities can be diagnosed before birth through prenatal testing such as ultrasound, blood tests, and amniocentesis. After birth, they can be diagnosed through physical examination, imaging studies, and genetic testing. Treatment for Congenital Abnormalities varies depending on the type and severity of the condition, and may include surgery, medication, and other forms of therapy. In some cases, the abnormality may be minor and may not require any treatment, while in other cases, it may be more severe and may require ongoing medical care throughout the person's life.

1) They share similarities with humans: Many animal species share similar biological and physiological characteristics with humans, making them useful for studying human diseases. For example, mice and rats are often used to study diseases such as diabetes, heart disease, and cancer because they have similar metabolic and cardiovascular systems to humans.

2) They can be genetically manipulated: Animal disease models can be genetically engineered to develop specific diseases or to model human genetic disorders. This allows researchers to study the progression of the disease and test potential treatments in a controlled environment.

3) They can be used to test drugs and therapies: Before new drugs or therapies are tested in humans, they are often first tested in animal models of disease. This allows researchers to assess the safety and efficacy of the treatment before moving on to human clinical trials.

4) They can provide insights into disease mechanisms: Studying disease models in animals can provide valuable insights into the underlying mechanisms of a particular disease. This information can then be used to develop new treatments or improve existing ones.

5) Reduces the need for human testing: Using animal disease models reduces the need for human testing, which can be time-consuming, expensive, and ethically challenging. However, it is important to note that animal models are not perfect substitutes for human subjects, and results obtained from animal studies may not always translate to humans.

6) They can be used to study infectious diseases: Animal disease models can be used to study infectious diseases such as HIV, TB, and malaria. These models allow researchers to understand how the disease is transmitted, how it progresses, and how it responds to treatment.

7) They can be used to study complex diseases: Animal disease models can be used to study complex diseases such as cancer, diabetes, and heart disease. These models allow researchers to understand the underlying mechanisms of the disease and test potential treatments.

8) They are cost-effective: Animal disease models are often less expensive than human clinical trials, making them a cost-effective way to conduct research.

9) They can be used to study drug delivery: Animal disease models can be used to study drug delivery and pharmacokinetics, which is important for developing new drugs and drug delivery systems.

10) They can be used to study aging: Animal disease models can be used to study the aging process and age-related diseases such as Alzheimer's and Parkinson's. This allows researchers to understand how aging contributes to disease and develop potential treatments.

The definition of AKI has evolved over time, and it is now defined as a syndrome characterized by an abrupt or rapid decrease in kidney function, with or without oliguria (decreased urine production), and with evidence of tubular injury. The RIFLE (Risk, Injury, Failure, Loss, and End-stage kidney disease) criteria are commonly used to diagnose and stage AKI based on serum creatinine levels, urine output, and other markers of kidney damage.

There are three stages of AKI, with stage 1 representing mild injury and stage 3 representing severe and potentially life-threatening injury. Treatment of AKI typically involves addressing the underlying cause, correcting fluid and electrolyte imbalances, and providing supportive care to maintain blood pressure and oxygenation. In some cases, dialysis may be necessary to remove waste products from the blood.

Early detection and treatment of AKI are crucial to prevent long-term damage to the kidneys and improve outcomes for patients.

There are several subtypes of RCC, including clear cell, papillary, chromophobe, and collecting duct carcinoma. The most common subtype is clear cell RCC, which accounts for approximately 70-80% of all RCC cases.

RCC can be difficult to diagnose as it may not cause any symptoms in its early stages. However, some common symptoms of RCC include blood in the urine (hematuria), pain in the flank or abdomen, weight loss, and fatigue. RCC is typically diagnosed through a combination of imaging studies such as computed tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans, along with a biopsy to confirm the presence of cancer cells.

Treatment for RCC depends on the stage and location of the cancer. Surgery is the primary treatment for localized RCC, and may involve a partial or complete nephrectomy (removal of the affected kidney). For more advanced cases, treatment may involve a combination of surgery and systemic therapies such as targeted therapy or immunotherapy. Targeted therapy drugs, such as sunitinib and pazopanib, work by blocking specific molecules that promote the growth and spread of cancer cells. Immunotherapy drugs, such as checkpoint inhibitors, work by stimulating the body's immune system to attack cancer cells.

The prognosis for RCC is generally good if the cancer is detected early and treated promptly. However, the cancer can be aggressive and may spread to other parts of the body (metastasize) if left untreated. The 5-year survival rate for RCC is about 73% for patients with localized disease, but it drops to about 12% for those with distant metastases.

There are several risk factors for developing RCC, including:

* Age: RCC is more common in people over the age of 50.
* Gender: Men are slightly more likely to develop RCC than women.
* Family history: People with a family history of RCC or other kidney diseases may be at increased risk.
* Chronic kidney disease: Patients with chronic kidney disease are at higher risk for developing RCC.
* Hypertension: High blood pressure is a common risk factor for RCC.
* Smoking: Smoking may increase the risk of developing RCC.
* Obesity: Being overweight or obese may increase the risk of developing RCC.

There are several complications associated with RCC, including:

* Metastasis: RCC can spread to other parts of the body, such as the lymph nodes, liver, and bones.
* Hematuria: Blood in the urine is a common complication of RCC.
* Pain: RCC can cause pain in the flank or abdomen.
* Fatigue: RCC can cause fatigue and weakness.
* Weight loss: RCC can cause weight loss and loss of appetite.

There are several treatment options for RCC, including:

* Surgery: Surgery is often the first line of treatment for RCC that is localized and has not spread to other parts of the body.
* Ablation: Ablation therapies, such as cryotherapy or radiofrequency ablation, can be used to destroy the tumor.
* Targeted therapy: Targeted therapies, such as sunitinib or pazopanib, can be used to slow the growth of the tumor.
* Immunotherapy: Immunotherapies, such as checkpoint inhibitors, can be used to stimulate the immune system to attack the tumor.
* Chemotherapy: Chemotherapy may be used in combination with other treatments or as a last resort for patients with advanced RCC.

The prognosis for RCC varies depending on the stage and location of the cancer, but in general, the earlier the cancer is detected and treated, the better the outcome. According to the American Cancer Society, the 5-year survival rate for RCC is about 73% for patients with localized disease (cancer that has not spread beyond the kidney) and about 12% for patients with distant disease (cancer that has spread to other parts of the body).

Here are some common types of E. coli infections:

1. Urinary tract infections (UTIs): E. coli is a leading cause of UTIs, which occur when bacteria enter the urinary tract and cause inflammation. Symptoms include frequent urination, burning during urination, and cloudy or strong-smelling urine.
2. Diarrheal infections: E. coli can cause diarrhea, abdominal cramps, and fever if consumed through contaminated food or water. In severe cases, this type of infection can lead to dehydration and even death, particularly in young children and the elderly.
3. Septicemia (bloodstream infections): If E. coli bacteria enter the bloodstream, they can cause septicemia, a life-threatening condition that requires immediate medical attention. Symptoms include fever, chills, rapid heart rate, and low blood pressure.
4. Meningitis: In rare cases, E. coli infections can spread to the meninges, the protective membranes covering the brain and spinal cord, causing meningitis. This is a serious condition that requires prompt treatment with antibiotics and supportive care.
5. Hemolytic-uremic syndrome (HUS): E. coli infections can sometimes cause HUS, a condition where the bacteria destroy red blood cells, leading to anemia, kidney failure, and other complications. HUS is most common in young children and can be fatal if not treated promptly.

Preventing E. coli infections primarily involves practicing good hygiene, such as washing hands regularly, especially after using the bathroom or before handling food. It's also essential to cook meat thoroughly, especially ground beef, to avoid cross-contamination with other foods. Avoiding unpasteurized dairy products and drinking contaminated water can also help prevent E. coli infections.

If you suspect an E. coli infection, seek medical attention immediately. Your healthcare provider may perform a urine test or a stool culture to confirm the diagnosis and determine the appropriate treatment. In mild cases, symptoms may resolve on their own within a few days, but antibiotics may be necessary for more severe infections. It's essential to stay hydrated and follow your healthcare provider's recommendations to ensure a full recovery.

... where the ureter meets the renal pelvis; where the iliac blood vessels cross the ureters; and where the ureters enter the ... The ureters are a component of the urinary system. Urine, produced by the kidneys, travels along the ureters to the bladder. It ... The ureters have been identified for at least two thousand years, with the word "ureter" stemming from the stem uro- relating ... The ureter is lined by urothelium, a type of transitional epithelium that is capable of responding to stretches in the ureters ...
... a duplex kidney with 2 ureters. In this case, usually one ureter drains correctly to the bladder, with the duplicated ureter ... Ectopic ureter (or ureteral ectopia) is a medical condition where the ureter, rather than terminating at the urinary bladder, ... "Duplicated Ectopic Ureter" (PDF). Retrieved 2009-02-10.[permanent dead link] "Diagnosis Of Ectopic Ureter As A Cause Of Urinary ... "An Ectopic Ureter". Retrieved 2007-12-01. "UrologyHealth.org - Pediatric Conditions: Abnormalities - Ectopic Ureter". Archived ...
Race Duplicated ureter is more common in White Americans than in African-Americans.[citation needed] Sex Duplicated ureter is ... Ureteral duplication is either of: Partial I.e., the two ureters drain into the bladder via a single common ureter. Partial, or ... Complete In which the two ureters drain separately. Complete ureteral duplication may result in one ureter opening normally ... the embryological origin of the ureter, splits (or arises twice), resulting in two ureters draining a single kidney. It is the ...
3. Ureter. 4. Urinary bladder. 5. Urachus. cl. Cloaca. cp. Elevation which becomes clitoris or penis. i. Lower part of the ...
The ureter opens at first into the hind-end of the Wolffian duct; after the sixth week it separates from the Wolffian duct, and ... 3. Ureter. 4. Urinary bladder. 5. Urachus. cl. Cloaca. cp. Elevation which becomes clitoris or penis. i. Lower part of the ... On one hand, the precursor of the ureter buds from the Wolffian duct, while on the other hand, the precursor of the renal ... The other, more superficial, portion of the diverticulum, on the other hand, becomes the ureter. The renal corpuscles and renal ...
"Enlarged ureter". Greifswald Medical School. 2015-12-18. Archived from the original on 2017-02-07. Retrieved 2017-02-06. Page ...
The cause is thought to be aperistalsis of the distal ureter, leading to dilatation.[citation needed] The cutoff value for ... A functional obstruction at the lower end of the ureter leads to progressive dilatation and a tendency to infection. The ... Megaureter is a medical anomaly whereby the ureter is abnormally dilated. Congenital megaureter is an uncommon condition which ... "Enlarged ureter". Greifswald Medical School. Archived from the original on 2017-02-07. Retrieved 2017-02-06. Page 140 in: ...
These include nephroureterectomy, or the removal of kidney, ureter, and bladder cuff, and segmental resection of the ureter. ... Ureter Histology at KUMC urinary-renal16 "ureter" www.urothelium.com is an online resource for information about Human ... It is also the leading cause of cancer of the ureter, urethra, and urachus, and the second leading cause of cancer of the ... This is an option only when the cancer is superficial and infects only the bottom third of the ureter. The procedure entails ...
This becomes the ureter. At the hilum, the ureter and renal vein exit the kidney and the renal artery enters. Hilar fat and ... Duplicated ureter occurs in approximately one in 100 live births Horseshoe kidney occurs in approximately one in 400 live ... Each kidney is attached to a ureter, a tube that carries excreted urine to the bladder. The kidney participates in the control ... The urinary tract including the ureters, as well as their function to drain urine from the kidneys, has been described by Galen ...
Other branches supply the ureter.[further explanation needed] The middle vesical artery, usually a branch of the superior ...
The ureter is also formed. Between the fourth and seventh weeks of development, the urorectal septum divides the cloaca into ...
The renal pelvis is the part of the kidney that collects urine and drains it into a tube called the ureter. The cells that line ... The transitional/urothelial cells in the renal pelvis are the same type of cells that line the ureter and bladder. For this ... "Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment (PDQ®)-Patient Version". National Cancer Institute. 2004-02- ... "Transitional Cell Cancer (Kidney/Ureter) Treatment". National Cancer Institute. 2019. Retrieved 8 June 2019. "Wilms Tumor and ...
There is apparently no secondary ureter. The buccal mass is small, about twice as long as wide, the oesophagus opening well ...
A small branch supplies the ureter. Spermatic cord Artery to the ductus deferens.Deep dissection. Lateral view. This article ...
doi:10.1016/B978-0-323-47781-9.50032-5. ISBN 978-0-323-47781-9. "Ureters and Bladder". Imaging Anatomy: Ultrasound (2nd ed.). ...
The surgery of the kidney and ureter). 1926. James Adolf Israel @ Who Named It Google Books Albany Medical Annals, Volume 28 ...
Uretectomy is the removal of the ureter. Uvulectomy is the removal of the uvula. Vaginectomy is the removal of all or part of ...
Confusingly however, at the time it was called "ureter". Thereafter, terms "ureter" and "urethra" were variably used to refer ... Marx, Franz Josef; Karenberg, Axel (2010). "Uro-words making history: Ureter and urethra". The Prostate. 70 (9): 952-958. doi: ... and Jacques Dubois began to use the terms to specifically and consistently refer to what is in modern English called the ureter ...
They supply the bladder and terminal ureter. The two most prominent are the superior vesical artery and the inferior vesical ...
Severe renal colic caused by kinking ureter. Pain classically relieved a little by going on all fours with hips higher than ...
"The Ureter, the Gynæcologist and the Urologist". President's Address in the Proceedings of the Royal Society of Medicine. Vol. ...
Treatment may involve removal of the kidney and ureter, or just the ureter. Classification of cancers often is oriented around ... "Transitional Cell Cancer (Kidney/Ureter) Treatment - National Cancer Institute". 2004-02-20. "Renal Pelvis and Ureter Cancer: ... In some contexts, the primary division is at the border of kidney and ureter, and in other contexts, the primary division is ... Because of this, neoplasia of the ureters are sometimes grouped with tumors of the renal pelvis. Ureteral cancer Shimoyama Y, ...
Ureter, Niere, Thranendruse. Verhandlungen der Anatomischen Gesellschaft auf der achten Versammlung zu Strassburg, vom 13-16 ...
"Single Vaginal Ectopic Ureter and the Vater Syndrome." The Journal of Urology. vol. 127, no. 6, 1982, pp. 1181-1182. Science ...
Ureter: The liquid urine leaves to the Ureter. Same principle is used in hemodialysis within artificial kidney machines. ...
Trigonitis Woodburne, Russell T. (1965-03-01). "The Ureter, ureterovesical junction, and vesical trigone" (PDF). The Anatomical ...
Compression of the ureter may lead to hydronephrosis. Fibroids may also present alongside endometriosis, which itself may cause ...
In Robotic Renal Surgery: Benign and Cancer Surgery for the Kidneys and Ureters (pp. 89-96). Springer US, 2013. Hyams ES, ... Robotic partial nephrectomy: The NYU technique Robotic ureteroureterostomy for the management of retrocaval ureter. Robotic ... Robotic ureteroureterostomy for the management of retrocaval ureter. Robotic partial nephroureterectomy for a duplicated ... partial nephroureterectomy for a duplicated collecting system and ectopic ureter. Robotic partial nephrectomy: Dealing with ...
"Yu Aku , aged 70, died of ureter cancer". nikkansports.com (in Japanese). Nikkan Sports. Retrieved 2008-12-04. Official website ...
Xu J, Qi X, Gong J, Yu M, Zhang F, Sha H, Gao X (2012). "Fstl1 antagonizes BMP signaling and regulates ureter development". ... FSTL1 has a role in development, such as lung development, ureter development, central nervous system development, and skeletal ...
But what was shocking when a doctor cut a woman ureter ... Womans ureter cut during uterus removal. Sheezan Nezami / TNN ... But what was shocking when a doctor cut a woman ureter while operating for hysterectomy. Ureter is a tube through which urine ... Talking particularly about the recent uterus removal in Muzaffarpur, in which the ureter was also cut, Dr Didwania said there ...
Ureteral disorders occur when ureters become blocked or injured, which affect the flow of urine to the bladder. Read more about ... The ureters are about 8 to 10 inches long. Muscles in the ureter walls tighten and relax to force urine down and away from the ... Injury - kidney and ureter (Medical Encyclopedia) Also in Spanish * Retroperitoneal fibrosis (Medical Encyclopedia) Also in ... Sometimes the ureters can become blocked or injured. This can block the flow of urine to the bladder. If urine stands still or ...
The International Society for Gynecologic Endoscopy was formed in 1989. We fulfill the need for a scientific group who meets at regular intervals to share their knowledge and expertise in gynecologic endoscopy.. The ISGE-website was formed by Tamer Seckin, MD in 1989.. ...
... Rudiger Anatomie Kidney and Ureter Laminated Anatomy Chart. (1 review) Write a Review ... Decrease Quantity of Kidney and Ureter Laminated Anatomy Chart Increase Quantity of Kidney and Ureter Laminated Anatomy Chart ... The Kidney and Ureter chart is an incredibly detailed and educational anatomy chart that displays dozens of illustrations of ... Kidney and Ureter Laminated Anatomy Chart. Rating Required Select Rating. 1 star (worst). 2 stars. 3 stars (average). 4 stars. ...
If the entire ureter needs to be removed, then an ile... ... If a ureter is partially damaged, it can be bypassed with a ... If the entire ureter needs to be removed, then an ileal ureter interposition can be considered. Colon could also potentially be ... Q: What is a ureter reconstruction option when most of the ureter needs to be replaced? show answer ... In some unusual instances, the damaged ureter is brought over and anastomosed to the normal ureter in a ...
Welcome to the Pathology Education Informational Resource (PEIR) Digital Library, a multidisciplinary public access image database for use in medical education. ...
TRPM3 channel activation inhibits contraction of the isolated human ureter via CGRP released from sensory nerves.. ... TRPM3 channel activation inhibits contraction of the isolated human ureter via CGRP released from sensory nerves. ... The aim of this study is to examine the role of TRPM3 activation in human ureter motility. ... TRPM3 channel activation inhibits contraction of the isolated human ureter via CGRP released from sensory nerves. ...
Powered by Pure, Scopus & Elsevier Fingerprint Engine™ © 2023 Elsevier B.V. We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies. ...
Ectopic ureter. Ectopic ureter is due to the insertion of the ureter in a location other than the lateral angle of the bladder ... Ectopic ureter is three to four times more common in girls than in boys and causes incontinence only in females. ... Children with ectopic ureter tend to wet constantly. Enuresis results when the insertion is distal to the external urethral ... The prognosis is excellent when enuresis is due to cystitis, ectopic ureter, OSA, diabetes mellitus, diabetes insipidus, or ...
C659 Renal pelvis C669 Ureter **Note 1:** This schema is based on the UICC chapter *Renal Pelvis and Ureter* pages 258-261. ** ... Renal Pelvis and Ureter Primary Site. Histology. Staging Type. C659, C669. 8000-8576, 8940-8950, 8980-8981. TNM 7 and Summary ... If directly assigning SS2000, use the *Renal Pelvis & Ureter* chapter on page 244 of the [SS2000 on-line manual](http://seer. ...
Affecting tubular structures connecting the kidneys and bladder, ureter cancer is a rare form of cancer thats more common in ... Visiting your doctor can help provide an early diagnosis of ureter cancer. ... Types of Ureter Cancer. The most common type of cancer that affects the ureter is squamous cell carcinoma, which affects ... Ureter cancer occurs when abnormal cells form in a tube that carries urine from the bladder to the outside of the body. For men ...
Surgery of the Ureter, is an excellent addition to the Encyclopedia of Urology. It is a concise but thorough and beautifully ... Volume XIII/3, Surgery of the Ureter, is an excellent addition to the Encyclopedia of Urology. It is a concise but thorough and ... Chapter 1 is a review of the surgical approach to the ureter. Well written and illustrated, it would stand its own merit, but ... Surgery of the Ureter. Arch Surg. 1976;111(9):1043-1044. doi:10.1001/archsurg.1976.01360270115029 ...
The ureters are small tubes, each about 10 in. (25 cm) long, that carry urine from the kidneys to the bladder. ...
Cistite Intersticial; Hidronefrose; Ureter; Cálculos Ureterais; Humanos; Ureter/cirurgia; Cálculos Ureterais/complicações; ... Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Assunto principal: Ureter / Cálculos ... Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Assunto principal: Ureter / Cálculos ... Ileal cystoplasty, ureterolithotomy and ureter replantation in a patient with right renal and ureteral calculi complicating ...
Malignant neoplasms of the renal pelvis; ureter; and other urinary organs.. * Malignant neoplasms of the eye and orbit. ...
Laparoscopic surgery of the kidney, ureter, upper urinary tract and adrenal gland. Home , Laparoscopy , Laparoscopic surgery of ... It is the removal of the kidney and the ureter, which is the tube through which urine from the kidney reaches the bladder. ... Usually this surgery is performed in cases of tumours of the ureter or renal pelvis (the part of the kidney where urine ... 3Laparoscopic surgery of the kidney, ureter, upper urinary tract and adrenal gland ...
... chapter-1-surgical-anatomy-of-the- ... https://TopgradeApp.com/playQuiz/chapter-1-surgical-anatomy-of-the-retroperitoneum-adrenals-kidneys-and-ureters-1. Other share ...
Ureter and urethra. *Male reproductive organs. Vascular surgery Common conditions: vascular conditions, varicose veins ...
The urinary tract includes the kidneys, ureters, bladder, and urethra.. The urinary tract includes two kidneys, two ureters, a ... Ureter defects. Birth defects in the ureter that cause hydronephrosis include. *ureteropelvic junction (UPJ) obstruction, in ... other defects of the ureter or where the ureter joins the bladder, which may prevent the normal flow of urine from the kidneys ... vesicoureteral reflux (VUR), in which urine flows backward, or refluxes, from the bladder to one or both ureters and sometimes ...
Imaging based case report of ectopic urethral ureter in an infant: A case report and literature review. Abstract. Kevin John ... upper pole moiety without bladder opacification on the voiding cystourethrogram due to direct canalization of the left ureter. ... diagnosis is important to prevent frequent urinary tract infections and urinary incontinence with lower ectopic urethral ureter ...
TCC left kidney and ureter; TCC bladder Feb. 2001. TCC left kidney and ureter; TCC bladder Feb. 2001 Post op RC with Studer ...
Urine exits the kidney through a long narrow tube called the ureter. The ureter exits into the bladder. It is in this ureter ... After the urine travels down the ureters, it enters the bladder, a stretchy pouch surrounded by muscle located just above your ... The urine travels from the kidneys through the ureters to the bladder, where it is stored until you urinate. ... During pregnancy, the fetus can obstruct the ureter since it is located close to the growing fetus. ...
Disorder of kidney and ureter, unspecified. N28.9P. Prevent kidney disease. N30. Cystitis. ...
A KUB X-ray provides an image of the abdominal region that includes the kidney, ureter and bladder. It is used to diagnose ... This is a urologic procedure in which contrast dye is injected into the ureter to allow for better visualization of the kidneys ... This procedure involves injecting a tracer substance into the arm and tracing its path through the kidneys, ureters and bladder ...
7. Batourina E, Choi C, Paragas N, Bello N, Hensle T, Costantini FD, Schuchardt A, Bacallao RL, Mendelsohn CL: Distal ureter ... TNXB is expressed in the UVJ of normal and refluxing ureters. Human UVL sections obtained from normal controls and patients ... Furthermore, a review of the publicly available database, GUDMAP, showed that TNXB is expressed in the ureter and bladder of ... Left to right: normal (nonrefluxing ureter) negative control, not stained with rabbit anti-TNXB antibody. There is absence of ...
Ureter 29040 Other Urinary Organs 30000 Eye and Orbit 31010-31040 Brain and Other Nervous System 31010 Brain ...
One 10 mg/kg male and one 30 mg/kg female had transitional epithelial carcinoma of the ureter. The incidences of dilatation and ... The marginally increased incidence of carcinoma of the ureter may have been related to TCAB administration. There was of ... The marginally increased incidences of carcinoma of the ureter and malignant lymphoma may have been related to TCAB ... Ureter: epithelial carcinoma (0/50, 1/50, 0/50, 0/50). Ureter: epithelial carcinoma (0/50, 0/50, 1/50, 0/50). Malignant ...
  • The urine travels from the kidneys to the bladder in two thin tubes called ureters. (medlineplus.gov)
  • Small amounts of urine flow from the ureters into the bladder about every 10 to 15 seconds. (medlineplus.gov)
  • Ureter is a tube through which urine passes from kidney to urinary bladder. (indiatimes.com)
  • A renal (REE-nul) ultrasound uses sound waves to make images of the kidneys, ureters, and bladder. (kidshealth.org)
  • Usually the bladder is brought upward toward the viable ureter with a reconstruction like a psoas hitch. (radiopaedia.org)
  • Abnormal findings might be present in patients with cystitis, constipation, neurogenic bladder, urethral obstruction, ectopic ureter, attention deficit-hyperactivity disorder (ADHD), or obstructive sleep apnea (OSA). (medscape.com)
  • The two ureters are muscular tubes that extend from the kidneys to the posterior surface of the urinary bladder. (the-definition.com)
  • Wednesday I had emergency Stent surgery to open up blockage at the top of the ureter so urine could flow from the kidney to my bladder so I could urinate freely. (sabeelhomeoclinic.com)
  • Affecting tubular structures connecting the kidneys and bladder, ureter cancer is a rare form of cancer that's more common in older adults. (uciurology.com)
  • Ureter cancer occurs when abnormal cells form in a tube that carries urine from the bladder to the outside of the body. (uciurology.com)
  • Linked to invasive bladder cancer , ureter cancer has a tendency to spread to nearby areas, including the vagina and bladder in women and the prostate and areas around the penis in men. (uciurology.com)
  • The most common type of cancer that affects the ureter is squamous cell carcinoma, which affects surface cells by the bladder in women and in the penis in men. (uciurology.com)
  • Because of the association with bladder cancer, patients being checked for signs of ureter cancer are often evaluated for abnormalities in the bladder. (uciurology.com)
  • It is the removal of the kidney and the ureter , which is the tube through which urine from the kidney reaches the bladder. (doctorantoniorosino.com)
  • The case is remarkable due to initial opacification of only the left upper pole moiety without bladder opacification on the voiding cystourethrogram due to direct canalization of the left ureter. (pediatricurologycasereports.com)
  • In vesicoureteral reflux (VUR) , developmental abnormalities in one or both ureters -- tubes connecting the kidneys with the bladder -- allow urine to flow back from the bladder into the ureters, and sometimes into the kidneys. (nih.gov)
  • Researchers are interested in determining the safest and most effective dose of this combined form of chemotherapy for solid tumors, particularly for urothelial cancer (tumors of the bladder, urethra, ureter, or renal pelvis). (nih.gov)
  • Patients must have a histologically confirmed diagnosis of urothelial carcinoma of the bladder, urethra, ureter, or renal pelvis. (nih.gov)
  • Patient must have a histologically confirmed diagnosis of non-transitional cell carcinoma of the bladder, urethra, ureter, or renal pelvis including but not limited to squamous cell, neuroendocrine, adenocarcinoma including urachal and sarcomatoid. (nih.gov)
  • C659 Renal pelvis C669 Ureter **Note 1:** This schema is based on the UICC chapter *Renal Pelvis and Ureter* pages 258-261. (cancer.gov)
  • The Kidney and Ureter chart is an incredibly detailed and educational anatomy chart that displays dozens of illustrations of the kidney and its relationships to adjacent structures. (anatomywarehouse.com)
  • Included are topographical views of the kidney in relation to the dorsal and ventral structures, arteries and ureters, multiple common kidney pathologies, anomalies in the kidneys and ureters, and more. (anatomywarehouse.com)
  • There are two ureters, one for each kidney. (the-definition.com)
  • Usually this surgery is performed in cases of tumours of the ureter or renal pelvis (the part of the kidney where urine produced is collected) and can usually be performed laparoscopically . (doctorantoniorosino.com)
  • Looking for ectopic ureters, ureteroceles, seeing if a mass is involving/obstructing a ureter, and maybe to see there is debris in the urine. (sonopath.com)
  • Prompt diagnosis is important to prevent frequent urinary tract infections and urinary incontinence with lower ectopic urethral ureter insertions. (pediatricurologycasereports.com)
  • Talking particularly about the recent uterus removal in Muzaffarpur, in which the ureter was also cut, Dr Didwania said there can be anatomical abnormalities and injury in the ureter. (indiatimes.com)
  • Comment: Dilation of the ureter (synonym: hydroureter) is most commonly associated with cases of obstruction. (nih.gov)
  • Dilation of the ureter should be diagnosed and assigned a severity grade. (nih.gov)
  • If ureter dilation is treatment related, the study pathologist should describe whether the lesion is unilateral or bilateral. (nih.gov)
  • If urine stands still or backs up the ureter, you may get a urinary tract infections . (medlineplus.gov)
  • Since ureter cancer responds better to early treatment, regular urological exams can be beneficial, especially for patients with a family history of cancers affecting reproductive organs or the urinary tract. (uciurology.com)
  • Morgan M, Ileal ureter interposition. (radiopaedia.org)
  • An ileal ureter interposition. (radiopaedia.org)
  • If the entire ureter needs to be removed, then an ileal ureter interposition can be considered. (radiopaedia.org)
  • In a way, the interposition graft concept is a variant of neobladder (such as an ileal conduit), except it is creation of a neo- ureter . (radiopaedia.org)
  • Ileal cystoplasty, ureterolithotomy and ureter replantation in a patient with right renal and ureteral calculi complicating hydronephrosis and interstitial cystitis. (bvsalud.org)
  • To compare the efficacy of the selective alpha(1A)-adrenoceptor antagonist silodosin with those of doxazosin, terazosin, and alfuzosin against alpha-adrenoceptor agonist-induced contractions in mouse and hamster ureters. (nih.gov)
  • The urine is propelled along the ureter by peristaltic contractions of the muscle coat, assisted by the filtration pressure of the glomeruli. (the-definition.com)
  • Vesicoureteral reflux due to an abnormal, shortened ureter. (nih.gov)
  • The ureters enter the pelvic cavity as they cross intervention can be planned. (who.int)
  • Transitional cell proliferative lesions of the ureter with hydronephrosis in B6D2F1/Cr mice. (nih.gov)
  • Since ureter cancer is often detected in later stages, surgery is often the recommended treatment option. (uciurology.com)
  • Surgery may only involve removal of all or part of the ureter if cancer is detected in an early stage. (uciurology.com)
  • Volume XIII/3, Surgery of the Ureter , is an excellent addition to the Encyclopedia of Urology . (jamanetwork.com)
  • The correct the injury was planned as soon as the patient uterine artery accompanies the ureter as it passes was fit for anaesthesia and surgery. (who.int)
  • What are surgical options to treat a ureter that needs to be partially replaced? (radiopaedia.org)
  • Chapter 1 is a review of the surgical approach to the ureter. (jamanetwork.com)
  • Visiting your doctor can help provide an early diagnosis of ureter cancer. (uciurology.com)
  • These include urine tests, x-rays, and examination of the ureter with a scope called a cystoscope. (medlineplus.gov)
  • The aim of variation of the course of the ureters probably history taking, examination and investigations was contribute to injuries in about 0.5% of cases (2). (who.int)
  • At the base of the cardinal endangering renal function, a preliminary ligament, the ureter passes over the uterine artery. (who.int)
  • Transitional cell carcinoma is a form of ureter cancer that usually develops in the prostate in men and around the opening of the urethra in women. (uciurology.com)
  • If directly assigning SS2000, use the *Renal Pelvis & Ureter* chapter on page 244 of the [SS2000 on-line manual](http://seer.cancer.gov/tools/ssm/SSSM2000-122012.pdf#page=244). (cancer.gov)
  • It's not clear what causes the DNA mutations and cellular irregularities associated with ureter cancer. (uciurology.com)
  • This is another proof that homeopathic medicine and treatment provide the right treatment for right ureter stone and left renal concretion. (sabeelhomeoclinic.com)
  • A urologist might perform a ureteroscopy with a lighted tube that has a camera attached to view the ureters. (uciurology.com)
  • In mouse ureters, silodosin (a selective alpha(1A)-adrenoceptor antagonist), doxazosin (a nonselective alpha(1)-adrenoceptor antagonist), terazosin (a nonselective alpha(1)-adrenoceptor antagonist), and alfuzosin (a nonselective alpha(1)-adrenoceptor antagonist) all shifted the norepinephrine concentration-response curve to the right. (nih.gov)
  • Figure Legend: Figure 1 Greatly dilated ureter (arrow) of probable familial origin from a male mouse. (nih.gov)
  • But what was shocking when a doctor cut a woman ureter while operating for hysterectomy. (indiatimes.com)
  • Dr. Sabeel treated Mr. Zahoor for ureter stone and renal concretion using homeopathic medicine in less than 60 days. (sabeelhomeoclinic.com)